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ABSTRACT 
There is a growing epidemic of obesity in the United States and a 
corresponding increase in the number of morbidly obese patients receiving healthcare. 
Despite the increasing focus and research on obesity over the years, the prevalence of 
obesity in the United States has continued to worsen. A stigma against obesity exists 
in the general public including among healthcare professionals. Attitudes and bias of 
healthcare professionals against obesity can negatively affect judgment and choices 
related to the enactment of care, affecting both the quality of healthcare delivered and 
patient outcomes. Studies have shown that stigmatization against groups of patients 
such as minorities affects healthcare outcomes, however there is a paucity of research 
related to outcomes of stigmatization against obese individuals. The purpose of the 
study was to determine if there is a difference in quality of nursing care as measured 
by medicating for pain between obese and non-obese post-surgical patients. It was 
hypothesized that obese individuals will receive less pain medication than non-obese 
individuals. An underlying assumption based on the literature was that stigmatization 
of obesity by nurses would be reflected in reduced administration of post-surgical pain 
medication. The greater the stigma present, the less pain medication will be 
administered.  
This study used a retrospective chart review of the electronic medical record of 
three hospitals within a single healthcare system to compare non-bariatric post- 
surgical pain treatment among normal weight, over-weight, and obese adult patients as 
a measure of nurses’ stigma.  The final data set contained a total of 1704 cases, with 
21.4% (n=365) normal weight, 21.4% (n=365) overweight, 21.4% (n=365) obesity 
  
class I, 17.1% (n=291) obesity class II, and 18.7% (n=318) obesity class III 
individuals. BMI scores ranged from 18.5 to 185.9 (M = 33.1, SD = 11.1). Findings 
showed differences in total dose of day one post-surgical pain medication among the 
normal, overweight, obesity class I, II, and III patients. Obesity class III patients 
received less pain medication than the obesity class I and class II patients and 
significantly less than the overweight patients. Simple linear regression analyses were 
used to determine the relationship between BMI and pain medication administration 
on postoperative day one and day two. Hierarchical linear regression was used to 
determine the relationship between dose on day one and day two and BMI, while 
taking into account other variables associated with stigma. The relationship between 
dose of pain medications and BMI was significant and negatively related. For every 
1% increase in BMI there was a .17% decrease in the total morphine equivalent dose 
of narcotic given on postoperative day one. When controlling for other factors related 
to stigma, there was a .25% decrease in dose for every 1% increase in BMI. Further 
research is needed to measure attitudes and biases of nurses along with their 
administration of pain medication to obese patients.  Addressing nurses’ stigma of 
obesity is essential to improving the quality of care of obese patients. 
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CHAPTER 1 
 
INTRODUCTION 
 
There is a growing epidemic of obesity within the United States (U.S.) as 
described by the Center for Disease Control and Prevention’s (CDC) Behavioral Risk 
Factor Surveillance System from 1990 to 2007 (Center for Disease Control and 
Prevention, 2008). In 1990, no states had an obesity prevalence of greater than or 
equal to 15%. By 2007, 30 states had an obesity prevalence of greater than or equal to 
25% and three states had a prevalence of greater than or equal to 30%. In 2013, no 
state had a prevalence of obesity less than 20%, 23 states were between 25% and 30%, 
18 states between 30% and 35%, and 2 states (Mississippi and West Virginia) had a 
prevalence of obesity of 35% or greater. The South had the highest prevalence of 
obesity (30.2%), followed by the Midwest (30.1%), the Northeast (26.5%), and the 
West (24.9%) (Center for Disease Control and Prevention, 2015). More than one-third 
(78.6 million) of U.S. adults are obese. 
Over the past decade, there has also been an increase in the number of 
morbidly obese patients receiving healthcare. This can be seen be examining the 
literature regarding bariatric surgery. Between 1998 and 2004, there has been 
approximately an 900% increase (13,386 in 1998 to 121,055 in 2004) in the number of 
bariatric surgeries, such as gastric bypass and banding procedures, performed (Zhao & 
Encinosa, 2007). The increase in bariatric surgeries is alarming because it suggests 
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that there has been a dramatic increase in the number of surgical patients who qualify 
(i.e., are morbidly obese) for bariatric procedures.  
Attitudes and bias of healthcare professionals against obesity can negatively 
affect judgment and choices related to the enactment of care, affecting both the quality 
of healthcare delivered and patient outcomes. Stigmatization of obesity has been 
described as having a negative impact on health and there are a few studies that have 
shown that obese individuals receive inferior healthcare when compared to that of 
normal weight individuals. For example, obese patients were less likely to receive pap 
smears, mammograms, and colorectal cancer screenings (Fagan, Wender, Meyers & 
Petrelli, 2011), as well as cervical and breast cancer screenings (Wee, McCarthy, 
Davis & Phillips, 2000). Physicians spend less time with these patients and were 
found to only give patients a separate diagnosis of obesity 14.4% of the time (Huang 
et al., 2004, Bleich, Pickett-Blakely & Cooper, 2011). This lack of a separate 
diagnosis was an important finding because obese patients were less likely to receive 
weight loss counseling or education without a diagnosis (Tsai & Wadden, 2009). 
It is important to study the effect of obesity on healthcare and health outcomes 
because of the magnitude of individuals that are affected.  In order to promote the best 
health outcomes in obese individuals, it is important to not only describe the 
stigmatization of obesity that occurs, but also to identify the consequences of that 
stigma. Despite this increasing focus and research on obesity over the years, the 
prevalence of obesity in the United States has worsened. Even with this attention, 
obese individuals still must access healthcare and stigma still exists among healthcare 
providers. There are research studies that show that stigmatization against other 
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groups of patients affects healthcare outcomes, but no studies could be found that were 
related to outcomes of stigmatization against obese individuals related to the treatment 
of pain. If stigmatization against obese patients and resultant reduction in the quality 
of healthcare can be documented, then interventions to reduce bias and improve 
healthcare for obese patients can be developed. 
Purpose of Research 
The purpose of the study is to determine if there is a difference in quality of 
nursing care as measured by medicating for pain between normal, overweight, and 
obesity class I, II, and III post-surgical patients. Treatment of pain is an important 
quality indicator for hospitals and effective treatment is a requirement of accreditation 
by the Joint Commission. The amount of pain medication received has been studied in 
other stigmatized groups, for example racial bias resulting in less pain medication 
received in the emergency department, but this has never been studied in relation to 
obesity stigma. It is hypothesized that there is a difference in the amount of pain 
medication administered between normal, overweight, obesity class I, II, and III 
patients that results from stigmatization of obesity by nurses The greater the stigma 
present, the less pain medication is administered. 
Research Questions. The research questions for this study are: 
1. What is the difference in the total morphine equivalent dose of post-surgical 
pain medication administered between normal weight, overweight, and obese 
(Class I, II, and III) adult non-bariatric surgery patients? 
2. What is the relationship between pain medication ordered and administered 
and the BMI of adult non-bariatric surgery patients? 
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3. What is the relationship between patients’ BMI and the receipt of post-surgical 
pain medication, when accounting for race, gender, age, insurance status, 
presence of psychiatric diagnosis, and pain score during hospitalization?  
Significance of the Study 
This problem was selected because of the increase in obesity in the United 
States and the increase in the number of obese individuals seeking healthcare. 
Stigmatization of obesity has no place in healthcare because of the potential to impact 
the lives of millions of individuals and increase healthcare costs. This study is 
important because it could contribute to an improvement in quality of care, decrease in 
healthcare costs, and an increase in quality of life of obese individuals. The study has 
personal importance due the researcher’s twenty-year nursing career in the operating 
room and being witness to the increased need for consideration of obese patients 
during care surrounding surgery. 
Theory 
Symbolic interaction is a useful theory in the development of knowledge 
related to obesity stigma because it can be used to generate a wide range of 
researchable hypotheses. Meaning is a central to understanding stigma and its effect 
on health outcomes. The meaning that nurses attribute to obesity can shape their 
definitions of situations and perspectives towards the patient. Studying these meanings 
and the ways of helping individuals to reappraise attitudes and definitions of situations 
may reduce stigma. The processes of symbolic interaction are useful in describing the 
range of reference groups utilized by nurses in healthcare, how perspectives and 
stigma arise within these groups, how these perspectives shape nursing practice, and 
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how they may change. The focus of future nursing research related to obesity stigma 
should be on understanding how negative perspectives arise and removing them by 
altering perspectives and definitions of situations, which should in turn remove 
stigmatizing actions and improve care provided to obese patients. 
Premises and Assumptions 
Premise 1. A major premise of symbolic interaction, and this study, is that 
nurses act toward obese patients based on the meaning they attach to being obese. 
Negative bias or stigma would be reflected in a reduced pain medication 
administration. If nurses attach being lazy or lack of self-control to obesity, then 
biased attitudes may occur.  
Premise 2. Another premise is that this meaning arises through interaction 
with others, for example medical students interacting with biased residents and 
physicians, or through observing the interactions of others in person or through the 
media. Negative attitudes toward and interactions with obese individuals can be seen 
daily through mass media.  
Premise 3. The final premise is that meanings are assigned and modified 
through an interpretive process. The meaning that individuals attach to things is 
constantly changing.  This can be seen in studies that described less negative attitudes 
towards obesity in individuals who are educated about the uncontrollable causes of 
obesity.  
Assumption. The major assumption of this study is that stigma of obesity is 
not just an attitude or bias, but translates into behaviors that effect the provision of 
care given by healthcare providers, meaning that there is a lower quality of care 
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provided to obese as compared to normal-weight individuals. This assumption reflects 
Premise 1 of Symbolic Interaction, whereby the meaning attached to something is 
reflected in actions toward it. 
Study Design 
Treatment of pain was used as an indicator of obesity bias/stigmatization 
among healthcare providers in this study. A retrospective chart review was performed 
that examined data from the data warehouse of a large Rhode Island healthcare 
system. The warehouse consists of multiple data bases that save data from the multiple 
electronic medical record applications that are used within the system. Data for this 
study was collected specifically from the medication administration, the admitting, 
and the computerized physician order entry application. Data from these systems will 
be utilized to determine any differences or relationships between a patient’s weight 
status, as measured by their body mass index (BMI), and the amount of postoperative 
pain medication they receive. The five BMI categories used in this study were 
determined based on classification by the Centers for Disease Control (2015) of 
normal (18.5 – 24.9), overweight (25 – 29.9) and the World Health Organization 
(2014) obesity class I (30 – 34.9), II (35 – 39.9), and III (≥40). The association of 
treatment of pain to obesity stigma has not been studied, but has been studied with 
other stigmatized groups, for example in minorities (Pletcher, Kertesz, Kohn & 
Gonzoles, 2008; Sabin & Greenwald, 2012).  
Summary of Chapters to Follow 
 In chapter 2, a review of the literature describes the concept of stigma and 
defines its properties. The prevalence of obesity stigma in healthcare and its effect on 
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patient care delivered by various types of healthcare providers is reviewed. Various 
theoretical approaches, and study designs are described. Chapter 3 describes the 
research design of this study, highlighting the sampling method and the variables 
chosen. It is important to understand why the variables were chosen and how they 
could account for other stigmatizing conditions, besides obesity, that may impact pain 
medication administration. Chapter 4 presents the research findings and reports the 
results from a one-way ANOVA to compare differences in medication administration, 
Chi Square to examine relationships between medication ordering and medication 
between the BMI categories, and regression analyses to determine the relationship 
between BMI and pain medication administration, while controlling for other variables 
identified as being associated with bias or stigma. Chapter 5 presents the discussion of 
the findings, limitations of the study, as well as implications for nursing research, 
practice, and education.
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CHAPTER 2 
 
REVIEW OF LITERATURE 
 
Concept of Stigma 
To “stigmatize” has been defined as to describe or identify in opprobrious 
(vulgar, slanderous, abusive) terms (Merriam-Webster.com, 2013).  Link & Phelan 
(2001) described stigmatization as the convergence of distinguishing and labeling 
human differences, linking labeled persons to negative stereotypes, separating “them” 
from “us”, and status loss and discrimination of the labeled person which co-occur in a 
power situation that allows the components of stigma to unfold.  
Stigma, and the resulting stigmatization, is a complicated, multifactorial 
concept that was first comprehensively examined in the works of Goffman (1963), and 
later adapted for various situations in psychology, sociology, and various healthcare 
professional literatures. Stigma has been much studied, but a unified definition 
remains elusive. Many studies provide no explicit definition, or they quote Goffman’s 
definition where stigma is an attribute that is deeply discredited (stigmatized). Many 
studies deconstruct stigma into a list of attributes possessed by the stigmatized, and do 
not examine it as a language of relationships (Goffman, 1963). The reason for this 
definitional ambiguity may be the fact that the study of stigma has been 
multidisciplinary and each discipline has applied a slightly different definition in order 
to fit a wide variety of professional lenses and situations (Link & Phelan, 2001). 
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Multiple definitions for this concept may be appropriate given the different research 
questions being asked, but it does contribute to confusion regarding stigma. 
The concept of stigma related to obesity can be defined by describing the 
stigma, the attitudes and biases related to the stigma, and the effect stigma has related 
to healthcare. The stigma of obesity sets individuals apart from those who are not 
obese. The stigma connotes a set of negative attributes for which an obese individual 
is stigmatized. The obese individual is seen in a negative light due to deficient morals, 
which causes others to act differently toward the individual. Stigmatization is less 
likely to occur if there is a perceived cause for the obesity. Research has been 
conducted that shows that the non-obese react more favorably to obese individuals 
only if they perceive that the excess weight is beyond the control of the individual, for 
example the presence of a thyroid condition. This sets up a condition of inequality 
where those who are perceived to lack control of themselves and do not have any 
biological excuse for being overweight will be treated less favorably. In a review of 
literature, Wright & Whitehead (1987) found that fatness was stereotyped and that the 
more it was perceived that an individual was responsible for their obesity, the more 
they were disliked. Obese individuals who presented with a condition, such as a 
thyroid problem, were judged as more likeable, having more self-control, and were 
judged more attractive than obese individuals who did not have a physical cause to 
their obesity (DeJong, 1980). Individuals who were educated regarding the 
controllable causes of obesity are more likely to endorse negative stereotypes than are 
individuals who were educated about the uncontrollable causes (Puhl, Schwartz & 
Brownell, 2005). 
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The nature of stigma is that it is present among groups that exist outside the 
societal norm. Crocker & Major (1989) described stigmatization as occurring towards 
oppressed social categories of people toward which others hold negative attitudes, 
stereotypes, and beliefs, who are vulnerable to being labeled as deviant, and are who 
targets of prejudice or victims of discrimination. The recipients of stigmatization 
receive a disproportionately poor interpersonal or economic outcome relative to 
members of the society at large. Also, a stigmatized group is an out group relative to 
the dominant group in a culture or society, whereas an out group is defined by 
reference to any particular in-group, regardless of which group holds the dominant 
position in the social hierarchy. Puhl & Brownell (2003) suggested that a stigmatized 
person possesses an attribute or characteristic that conveys a social identity that is 
devalued in some particular social context. Puhl & Brownell (2006) also associated 
stigmatization with weight bias and stereotyping. Balogh-Robinson (2011) described 
stigmatization as a weight bias, prejudice, discrimination, or stereotype. Stigmatization 
occurs when any personal attribute is deeply discredited to its possessors; including 
“tribal stigmata,” “abominations of the body,” and “blemishes of individual character” 
(Goffman, 1963). Goffman also described it as the relationship between an attribute 
and a stereotype. Lewis & Van Puymbroeck (2008) described stigmatization as the 
discriminatory acts that result from the social disapproval tied to existing negative 
attitudes toward people perceived as being overweight. 
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Stigma and Healthcare 
Prevalence. The prevalence of stigma as described within the literature 
encompasses many examples of socially unacceptable conditions which are 
stigmatized.  In performing a literature search using the Cumulative Index to Nursing 
and Allied Health Literature (CINAHL) database and “stigmatization” as a key word, 
601 results were returned that were published between 1987 and 2013. A vast majority 
of the literature on stigmatization during this time period was related to mental illness 
and HIV infection. Stigmatization in obese individuals is the area of interest for this 
author. There is very little research of this facet of the stigma concept. Performing a 
literature search using CINAHL and “stigmatization” and “obesity” as keywords 
returned 29 results between published between1994 and 2013. Most of the articles 
focused on the attributes of stigma and the effects of stigmatization of obese 
individuals. 
Groups affected by stigma. Stigma associated with certain groups requiring 
healthcare is very prevalent within society. It is described as affecting multiple groups 
of individuals and occurs in every culture. Stigma has been described within multiple 
groups, such as stigma related to HIV/AIDS (Herek, Capitanio &Widaman, 2002; 
Letamo, 2003; Vanable, Carey, Blair & Littlewood, 2006), mental illness (Alonso et 
al., 2009; West et al., 2011), illicit drug use (Ahern, Stuber & Galea, 2007), epilepsy 
(Jacoby & Austin, 2007), smokers (Stuber, Galea & Link, 2008), and skin disorders 
(Chaturvedi, Singh & Gupta, 2005). The common thread that these different types of 
stigma share with obesity stigma is that the individual possesses and/or displays a 
mark or behavior that identifies them as belonging outside what is normal or 
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acceptable in society. Stigmatization of a group occurs whether it is perceived that the 
stigma may or may not be the fault of the individual. 
The characteristics of stigma are typically defined by the attributes being 
stigmatized. Stigma related to HIV is associated with homosexuality, promiscuity, and 
drug use. Stigma related to mental illness can be associated with inappropriate or 
bizarre behaviors, instability, and lack of personal hygiene. Stigma related to drug use 
is associated with lack of morals, criminal behavior, and drug addiction as a disease. 
The stigma of epilepsy is characterized by having a perceived mental illness, being 
possessed, and lacking intelligence. Stigma related to smoking is associated with 
lacking willpower and putting one’s health, or another’s health, at risk. Stigma related 
to skin diseases is associated with being unclean. Characteristics of stigma such as 
controllability, concealability, and entitativity, greatly affect psychological and 
behavior reactions to the stigma (Major & O’Brien, 2005) If the stigma is controllable, 
then individuals are more likely to possess negative attitudes and bias toward the 
stigma. Stigma that is concealable is less likely to be stigmatized, yet individuals may 
feel shame and may spend considerable effort trying to hide stigmatized attributes. 
Entitativity relates to the cohesiveness of a group. The presence of stigmatized 
attributes can activate stereotypic beliefs that cause them to be considered not only 
physically, but psychologically similar to other members of the group. For example, 
the stereotypic belief that obese individuals are lazy and lack willpower may be 
applied to all obese individuals. 
Effects of stigma. Stigma can greatly affect an individual who is stigmatized 
and multiple consequences that can occur. Stigma has been described as decreasing 
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self-esteem, lowering academic achievement, and placing an individual at greater risk 
for mental and physical health problems (Major & O’Brien, 2005).  Link & Phelan 
(2006) described stigma as affecting employment opportunities, housing, access to 
medical care, and exposure to chronic stress. Holzemer et al. (2009) described the loss 
of social support, persecution, isolation, job loss and problems accessing healthcare 
services resulted from stigma. Self-esteem has been found not to decrease in 
stigmatized individuals proportionally to the amount they are devalued by society. 
Crocker, Cornwell & Major (1993) described that self-esteem in overweight women 
may be increased by externalization of the cause of negative feedback, moving away 
from blaming oneself. Those who internalized the causes of negative feedback 
demonstrated lower self-esteem. In academic achievement, stigmatized individuals 
may receive less attention and support. Stigmatization directly affects health exposing 
individuals to physical and social environments that are more toxic and stressful and 
by limiting their access to quality medical care. 
Stigma of obesity related to healthcare professionals. Negative attitudes and 
beliefs related to obesity exist in the literature among healthcare students and 
professionals. Negative or biased attitudes, such as slow, like food, overeat, are 
insecure, and have low self-esteem, were described as present in physician assistant 
students (Wolf, 2010) where 13.6% of the physician assistant students studied 
displayed a high level of fat phobia. Waller, Lampman & Lupfer-Johnson (2012) 
described weight bias in nursing and psychology students. Both student groups 
displayed a significant implicit weight bias that was greater towards women than men. 
Nursing students were also described as having fat phobia and negative attitudes 
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toward obese patients (Poon & Tarrant, 2009). Registered nurses were compared to 
nursing students in the study and had a significantly greater fat phobia. Both groups 
perceived obese people as liking food, over eaters, shapeless, slow, and unattractive. 
Dietetic students were more likely to describe a poor health status and diet quality 
towards obese patients, even with identical health profiles among all individual 
scenarios (normal and overweight)(Puhl, Wharton & Heuer, 2009). These students 
displayed a moderate amount of fat phobia and rated obese patients as less likely to 
comply with treatment. Persky & Ecclesten (2011) described that medical students 
displayed more negative stereotyping towards obese patients, as well as rating them 
less likely to comply with treatment recommendations. Students attributed more 
responsibility to obese patients for potentially weight-related health problems.  Few 
medical students who have fat bias are aware of this bias (Miller et al., 2013). Due to 
the common lack of explicit bias in healthcare providers, other measures are needed to 
determine the presence of implicit bias. This could be accomplished with use of a 
scale that measures implicit bias in combination with a measure of patient outcomes 
among stigmatized and non-stigmatized groups. The presence of stigmatization in 
healthcare students is disturbing because of the potential that they will carry these 
attitudes and biases forward into practice. There may be a great opportunity to change 
attitudes in healthcare by focusing more study on students. This lack of bias awareness 
also holds true for other healthcare providers, such as physicians. A review of studies 
measuring implicit bias in physicians towards stigmatized groups found that obese, 
black, Hispanic, elderly, and women patients were the target of more bias (Chapman, 
Kaatz & Carnes, 2013).  
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Hebl & Xu (2001) described physician responses to mock medical records of 
patients who were average, overweight, and obese presenting with a migraine 
headache. Physicians viewed heavier patients more negatively and reported that they 
would spend less time with them than average weight patients. Physicians were more 
likely to perceive their obese patients as non-adherent to medications (Huizinga et al., 
2010), which has been shown in other studies to affect physician prescribing patterns. 
Patients perceived as non-adherent may not receive guideline recommended care and 
may result in a delay in prescribing recommended medications for HIV, acute 
coronary syndrome, and hemophilia, or intensifying therapy for diabetes. A clinician’s 
own body weight also affects healthcare received. Patients reported less confidence in 
care provided by overweight physicians (Hash, Munna, Vogel & Bason, 2003) and 
thin and overweight pediatricians reported more difficulty with weight loss counseling 
than average weight physicians (Perrin, Flower & Ammerman, 2005). Attitudes and 
bias of healthcare professionals towards obesity are often not explicitly demonstrated, 
but implicit (Schwartz et al., 2003). The stigma of obesity may affect healthcare 
professionals and create implicit bias. This can negatively affect judgment and choices 
related to the enactment of care, affecting both the quality of healthcare delivered and 
patient outcomes, as described by several research studies (Ǿstbyte, Taylor, Yancy & 
Krause, 2005; Tsai & Waden, 2009; Bertakis & Azari, 2005; Huang et al., 2004). To 
improve patient outcomes, healthcare providers should raise their awareness of any 
implicit bias. 
 Obesity stigma and healthcare outcomes. Stigmatization of obesity has been 
described as having a negative impact on health and healthcare. Many studies have 
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shown that obese individuals receive inferior healthcare when compared to normal 
weight individuals, such as less screenings for mammography or Pap smear (Ǿstbyte 
et al., 2005).  In a review of literature, Fagan, Wender, Meyers & Petrelli (2011) 
described a negative association between weight and pap smears, mammography, and 
colorectal cancer screenings. Overweight and obese women were described as less 
likely to be screened for cervical and breast cancer (Wee, McCarthy, Davis & Phillips, 
2000). Tsai & Wadden (2009) described absence, or less than recommended weight 
loss counseling in obese patients. Bertakis & Azari (2005) found that primary care 
physicians spent less time educating their obese patients about their health and spent a 
greater portion of the visits on technical tasks, such as history taking, performing the 
physical examine, giving feedback and planning treatment, and performing in-office 
procedures than with non-obese patients. Huang et al. (2004) found that obesity was 
documented as a separate clinical diagnosis in only 14.4% of patients with a BMI of 
30 or higher. Patients who did receive a diagnosis were more likely to receive weight 
counseling compared to those did not. Obese patients without a diagnosis are often 
counseled regarding their weight only if they have other health issues. Patients with a 
body-mass index (BMI) ≥ 35 or with Type 2 diabetes were more likely to report being 
counseled to lose weight than those without diabetes or patients with < 35 BMI. Obese 
patients often do not receive an obesity diagnosis (Bleich, Pickett-Blakely & Cooper, 
2011). While diet and exercise counseling were more likely to occur with a diagnosis 
of obesity, pediatric care providers were more likely to provide diet and exercise 
counseling than other specialties, including family physicians and general practice 
providers (Cook, Weitzman, Auinger & Barlow, 2005). 
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Postoperative Pain. This study examined the treatment of postoperative pain 
and its relationship to a patient’s BMI. Postoperative pain is an important topic to 
study since it has significant effects on health outcomes, such as increased lengths of 
hospital stay and delays in returning to activities of daily living (Morrison et al., 
2003). Pain greatly affects the patient’s ability to ambulate and immobility has been 
described as increasing 6-month mortality rates (Siu et al., 2006), while early 
ambulation has been associated with quicker return of functional capacity and a 
greater discharge to home after surgery (Oldmeadow et al., 2006). Mental status 
decline in geriatric patients has also been described in relation to the presence of 
postoperative pain (Lynch et al., 1998; Duggleby & Lander, 1994). A decrease in 
postoperative myocardial ischemia has been found in elderly patients receiving 
effective pain control after surgery (Scheinin et. al, 2000). 
Stigma and treatment of pain in other stigmatized conditions.  While the 
study of bias and its effect on the treatment of pain has not been studied in obese 
patients, it has been studied as it relates to other groups. Stigma related to the 
provision of healthcare and the treatment of pain has been described in association 
with age, gender, race, and mental illness. 
Studies have described that age is a factor in receiving analgesia, with older 
adult patients receiving less than younger patients (Jones, Johnson & McNinch, 1996). 
Also, several other age-related factors have been described among older adult patients 
that may affect the administration of pain medication, such as challenges of 
assessment of pain in older adults, the under reporting of pain, atypical manifestation 
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of pain in older patients, and misconceptions regarding tolerance and addiction 
(Cavalieri, 2005). 
Women experiencing more severe pain than men (Cepeda & Carr, 2003), and a 
gender bias has been describe in pain management, with women receiving more 
analgesia than men (Fillingim et al., 2009). In a review of the literature, Hoffmann & 
Tarzian (2001) found that women were less likely to be taken seriously and receive 
adequate treatment for pain. Pain was often ascribed to psychiatric causes in women. 
In a study examining the effect of race and gender on physician pain management 
decisions, Weisse, Sorum & Dominguez (2003) found that physicians treat women 
less aggressively for pain. 
In studies related to bias and race, treatment of pain has been demonstrated to 
be less in minorities than in white patients (Pletcher et al., 2008; Sabin & Greenwald, 
2012) and in black patients, unless they exhibited demanding or angry behavior 
(Burgess et al., 2008). Mills et al. (2011) described that nonwhite patients who 
presented to the ED for pain were less likely than whites to receive analgesia and 
waited longer for their opiate medication. Pletcher et al. (2008) described differential 
prescribing of opioids by race/ethnicity for all types of pain. In a study examining the 
effect of implicit bias on pediatric physicians’ treatment recommendations, Sabin & 
Greenwald (2012) found an association between implicit bias and patient’s race in 
prescribing a narcotic medication for pain following surgery. It is possible that 
treatment of pain may also be lacking in other stigmatized groups, such as in obese 
patients. 
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Insurance status has been used in multiple studies (Vijayakumar, et al., 1995; 
Hong, Baumann, & Boudreaux, 2007) as an indicator of socioeconomic status. Bird & 
Bogart (2000) have described it as a perceived reason for discrimination during 
healthcare provision. 
Having a psychiatric diagnosis is a stigmatized condition and is associated with 
poorer healthcare outcomes (Zolnierek, 2009). Patients with psychiatric diagnoses 
often have their physical health problems attributed to their mental illness 
(Thornicroft, Rose & Kassam, 2007). Primary care providers have been described as 
having significantly increased negative attitudes towards patients with mental illness, 
as described by the presence of stereotyping and attributing of negative attitudes 
(Mittal et al., 2014). 
Theoretical Approaches 
There are several theoretical approaches that have been described as guiding 
research in obesity stigma. Among these are a psychobiological approach, Attribution 
Theory (Puhl & Brownell, 2003), Social Support Theory (Peterson & Bredow, 2009), 
and Socioecological Systems model (Steele et al., 2011), Symbolic Interaction 
(Martins & Burbank, 2011; LaBat & DeLong, 1990; Schroeder, 1981), Critical Social 
Theory (Martins & Burbank, 2011; Monaghan, 2005), and Critical Interactionism 
(Martins & Burbank, 2011). 
Psychobiological. The Psychobiological approach could provide nurses with 
insight into the mechanisms that control energy intake and expenditure and has been 
used by nurses to gain understanding of obesity and to provide education to obese 
patients. When one understands the causes that lead to weight gain, they can better 
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modify behaviors or the environment to alleviate these causes. This approach 
incorporates understanding of the biological effects on weight management, such as 
hunger, craving, hedonic sensations, appetite, meals and their constituents, 
metabolism, and interactions with brain. Also incorporated is the idea of negative 
feedback and that if individuals eat too quickly, they may eat a larger portion before 
satiety signals are stimulated. The environment is also important in that nurses and 
patients can identify triggers of overeating and reduce or eliminate them. 
Understanding metabolism can help identify ways of increasing activity; taking into 
account domestic, financial, and environmental factors; which will increase 
metabolism and decrease the effect of starvation metabolism. Understanding energy 
intake is also important since self-report food intake is often underestimated. 
Additional nutrition-focused education could stress the need for more accurate 
assessment of energy intake. 
Attribution Theory. Attribution Theory deals with beliefs about reasons for 
obesity and for weight loss failure. Perception of control, both internal and external, is 
an important concept. Internal control assumes that an individual has a greater control 
over things, while external control assumes that what happens is out of individual 
control. Patients who perceive that they have greater control have greater weight loss 
success. In relation to stigmatization, individuals are more likely to stigmatize obese 
individuals if they perceive that the cause of the obesity is attributed to controllable 
causes rather than uncontrollable causes, such as thyroid disease (DeJong, 1980). 
Those who were educated regarding the uncontrollable causes demonstrated less 
obesity stigmatization. 
 21 
 
Social Support Theory. Environmental stressors, such as stigmatization, can 
affect health. Social Support Theory explains the mediating effect of support on 
coping with these stressors. It would be important for nurses to explore with 
individuals the extent of social contacts and how much perceived support they have. 
Greater support may potentially reduce environmental stress. Support can be in the 
form of emotional, informational, instrumental, or appraisal (Peterson & Bredow, 
2009). 
Socioecological Systems Models. Obesity stigma is a multifactorial issue and 
a socioecological model would be useful in determining the individual, family, 
nurse/clinician, institutional, and societal factors that may increase or decrease stigma 
(Steele et al., 2011).  These systems exist as nested structures, moving from the 
innermost structure outward. The structures are microsystems, mesosystems, 
exosystems, macrosystems, and chronosystems (Bronfenbrenner, 1994). In relation to 
obesity stigma, microsystems consist of activities, roles, and relationships experienced 
by the obese individual in a given setting with specific physical, social, and symbolic 
attributes that permit or inhibit engagement or activity in the immediate environment. 
Mesosystems are made up of the linkages and processes between two or more settings 
containing the obese individual, such as the relationship between home and a 
particular healthcare setting. Exosystems are comprised of linkages and processes that 
occur between two or more settings where at least one does not contain the obese 
individual, but where events occur that affect them. Macrosystems are comprised of 
the overall pattern of micro, meso, and exosystems and could be considered “as a 
societal blue-print for a particular culture or subculture” (Bronfenbrenner, 1994, p. 
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40). The chronosystem comprises the change over time of characteristics of an 
individual and their environment. 
Symbolic Interaction. One commonly used theoretical perspective that is 
helpful in guiding research in the area of obesity stigma is symbolic interaction. 
Following the theoretical framework, the actions of human beings toward things are 
based on the meaning that human beings attribute to them. This meaning is the result 
of social interaction and can change based on how humans interpret encounters with 
others (Blumer, 1969). The world exists separately from the individual, but can only 
be interpreted through the use symbols in the process of interaction. Objectivity can 
only be approximated because the world is seen through the lens of meaning derived 
by many individuals. 
There are three main premises that underpin symbolic interaction. The first is 
that humans act toward things based on the meaning that they attach to them. The 
second is that meaning comes from social interaction. The third premise is that 
meanings are assigned and modified through an interpretive process. In relation to 
obesity stigma, nurses act toward obese patients based the meaning they attach to 
being obese. If nurses attach being lazy or lacking of self-control to obesity, then 
biased attitudes may occur. This meaning may arise through interaction with others, 
for example medical students interacting with biased residents and physicians, or 
through observing the interactions of others in person or through the media. Negative 
attitudes toward and interactions with obese individuals can be seen daily through 
mass media. The meaning that individuals attach to things is constantly changing.  
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This can be seen in studies that described less negative attitudes towards obesity in 
individuals who are educated about the uncontrollable causes of obesity.  
Within situations, actions arise based on an individual’s own interpretation of 
meaning. Stigmatizing actions by nurses towards obese individuals can be explained 
using this symbolic interaction process (Burbank & Martins, 2010). Following the 
process, nurses have interactions with reference groups that shape their perspectives 
regarding obese individuals. These groups can be medical and healthcare 
organizations, or society at large. When an obese individual enters into the healthcare 
system and interacts with the nurse, negative perspectives fostered by these reference 
groups can help define the situation. An important definition of the situation with 
nurse-obese patient interactions is the attribution of the causes of obesity and whether 
or not the obese individual is in control of their weight gain. The perspectives and 
definitions of the nurse drive actions, and obese individuals may receive less care if it 
is perceived that the cause of their obesity was within their control. Nurses would feel 
justified in their negative perspectives if the obese individual meets the nurse’s 
expectations of someone who lacks self-control and is not taking an active role in 
reducing their weight by displaying healthcare avoidance behaviors or poor self-
esteem/depression, and they would continue to display a negative perspective or bias 
towards obese patients. 
Critical Social Theory. “Karl Marx believed any understanding of human 
societies must begin with the material conditions of human existence, or the 
economics of producing the necessities of life. The economic mode of production, due 
to its importance, influences other aspects of life, such as political organization, 
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ideology, religion and culture: ‘the ideas of the ruling class are in every epoch the 
ruling ideas: that is, the class which is the ‘ruling material force’ of society, is at the 
same time its ruling intellectual force’” (Marx & Engels, 1994, p. 15). Marxist writers 
authors would analyze obesity stigma as a social problem that is directly linked to the 
changing mode of production: definitions of obesity stigma and other social problems 
are influenced by both the economic and social structures and the core values of 
particular modes of production existing in a historical time period. The goal of critical 
theory is to create a life free from unnecessary domination (Kim & Holter, 1995). 
Habermas described a framework for knowledge specified within three 
categories; technical, practical, and emancipatory cognitive interest (Kim & Holter, 
1995). Technical interest is achieved through the application of empirical-analytic 
science and predictive knowledge is obtained. Understanding in social life is the 
orientation of practical interest and is achieved through reflective judgement and 
interpretive understanding evident in the historical-hermeneutic sciences. Knowledge 
gained through these two categories is not sufficient for full understanding of social 
phenomenon. Critical theory goes beyond knowledge gained through empirical-
analytical and historical-hermeneutic sciences by examining power relationships and 
creating knowledge oriented toward liberating individuals from domination through a 
process of self-enlightenment. 
The medicalization of obesity is evidenced by the increase focus on obesity as 
a health problem. Much effort and money is spent in the media, weight loss 
supplements and programs, and bariatric surgeries. Even with all this effort, stigma 
exists because obesity exists as both a medical and a social problem. The stigma of 
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obesity could be considered a result of ideological hegemony, or how relationships of 
domination and exploitation are embedded within the dominant ideas of society 
(Burbank & Martin, 2010). The implicitness of negative attitudes regarding obesity in 
healthcare relates how society has internalized the idea that obesity is brought upon 
oneself by sloth and overindulgence. Obese patients accessing healthcare are in a 
vulnerable position and possess little social power in the nurse/clinician-patient 
relationship. Patient encounters, such as the administration of pain medication by a 
nurse to a patient, exist on the micro level. Habermas’ communicative action theory, 
which emerged from critical theory, would allow linkage of macro 
societal/organizational issues to the micro level of the patient encounter. 
Critical Interactionism. Another framework that would be useful in the study 
of obesity stigma would be critical interactionism. Critical social theory and symbolic 
interaction are combined, taking into consideration both downstream and upstream 
factors when developing research related to obesity stigma. Martins & Burbank (2011) 
compared and contrasted symbolic interaction and critical social theory and described 
areas of divergence and synergy (Table 1). Obesity stigma is a complex health issue 
and involves the individual and professional groups, healthcare organizations, and 
society at large. Both micro and macro approaches need to be incorporated into 
interventions designed to alleviate the stigma. 
Other theories. Other theoretical approaches included theories on self-
fulfilling prophesy, attributional ambiguity, stigma-induced identity threat model 
(Major & O’Brien, 2005), social consensus model (Puhl & Brownell, 2003). Bos, 
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Pryor, Reeder & Stutterheim, (2013) proposed a model of stigma that incorporated 
structural, public, and self-stigma and stigma by association. 
Measures of Stigma 
Negative attitudes exist within stigmatized groups, such as obese individual. 
Scales have been used to assess attitudes of obese individuals towards obesity and 
obese patients. Friedman et al. (2005) described the use of the Attitudes Toward Obese 
Persons Scale, has been used to assess internalization of anti-fat attitudes by obese 
patients, and the Beliefs About Obese Persons Scale which assesses beliefs about the 
controllability of weight. Wang, Brownell & Wadden (2004) used the Implicit 
Association Test (IAT) to investigate the internalization of anti-fat bias among 
overweight individuals. 
Scales have also been used to assess attitudes of healthcare providers.  The Fat 
Phobia Scale has been used to assess attitudes toward obese patients (Poon & Tarrent, 
2009; Puhl, Wharton & Heuer, 2009; Wolfe, 2010). The Weight Implicit Association 
Test (IAT) has been used in studies (Miller et al., 2013; Schwartz et al., 2003) to 
assess implicit weight bias. Poon & Tarrent (2009) described the use of the Attitudes 
Toward Obese Adult Patients (ATOAP) scale to assess attitudes toward the 
management of care of adult obese patients. Measuring the length of visual contact has 
also been used to assess attitudes toward obese patients (Persky & Eccleston, 2011). 
Many studies described the sole use, or use with a scale, of surveys created by 
the researchers for the particular study. Wadden et al. (2000) administered a 
questionnaire to women participating at obesity trials and assessed views of weight 
control management provided by their primary care physician to compared satisfaction 
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scores and association with weight. Foster et al. (2003) conducted a self-reported 
survey of physicians’ attitudes about obesity and its treatment that assessed beliefs 
about causes of obesity, attributes of obese individuals, beliefs about treatment, 
attitudes about weight loss outcomes, and beliefs about the efficacy of obesity 
treatment. Brown et al. (2007) used a questionnaire to determine nurses’ practice, 
beliefs and attitudes related to obesity management and assessed clinical practice 
activities of assessment, advice, support, and referral, beliefs about causes and 
consequences of obesity, attitudes toward obese patients or clients, and views on 
obesity-related practice development, organizational support and training. Sack et al. 
(2009) used a mail survey, adapted from a survey assessing physician attitudes, to 
determine the attitudes of physical therapists related to attitudes and management of 
obese patients. Forman-Hoffman, Little & Wahls (2006) used a focus group survey to 
determine physician barriers to obesity care. Puhl, Wharton & Heuer (2009) created a 
survey rating dietary quality, receptivity of treatment recommendations based on 
patient profiles in order to assess weight bias among dietetic students. 
While relatively easy to administer, a majority of scales used in studies to 
assess attitudes toward obese patients are self-reported measures. Study participants 
that have concerns related to privacy issues, or how they might personally be 
perceived, may have a tendency to under report negative attitudes and over report 
positive attitudes.  Participants may feel more motivated to bias their responses if they 
are expressing socially undesirable behaviors, the questions are of a highly sensitive 
nature, the participants have a disposition to give socially desirable answers, or there is 
pressure on the participant to give desirable answers. 
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Tests that are designed to measure implicit bias that participants may not even 
be aware of can alleviate the issues of self-reported measures. The IAT works by 
measuring the length of time it takes to categorize a list of words. Pairing of word and 
category is easier if the pairing matches the participant’s attitude. Shorter pairings are 
attributed to a greater bias, whether positive or negative. Measurement of visual 
contact, for example between a healthcare provider and an obese patient, also could be 
an unconscious indicator of attitude. For these two methods to be effective, 
participants would need to be unaware of the purpose of the measurements. Length of 
time it takes to create word-category category pairings, or visual contact time, could 
be consciously increased by participants in order not to appear biased. Measurement 
equipment must be incorporated into the study and may reduce flexibility of 
administration. Paper surveys can be administered anywhere, but these types of 
measures may be limited to a particular area that has computers, particular software, or 
hardware such as the cameras to measure visual contact. 
Surveys created by researchers are highly specific for answering research 
questions, yet most often are not tested for validity or reliability. The specificity may 
prevent results from being generalizable. On the other hand, if researchers create 
questions that are too general, they may not apply to participant as they should. Some 
studies have described the use of tested scales in addition to these created surveys to 
lend more validity. Surveys, whether self-administered or administered by an 
interviewer, are self-reporting, therefore would be subject to the same variances 
related to bias as all self-reporting measures. 
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The issue of social desirability is an important consideration for all self-
reported measures that assess negative or sensitive issues (Krumpal, 2013). The 
likelihood of participants telling the truth depends on the perceived risk related to 
socially undesirable situations. Participants may fear embarrassment, reactions of an 
interviewer, reactions from family and friends present, or retribution such as loss of 
job or position. A threat to one’s self concept may occur in answering questions 
negatively that may make them look bad. Nurses want to believe that they treat 
everyone equally and holistically. 
There are several ways to minimize and control for the effect of social 
desirability bias (Nederhof, 1985). A self-administered survey may increase the 
likelihood of accurate reporting since there is a higher degree of anonymity than if the 
survey was administered by an interviewer, although there may be issues with 
participants not answering sensitive questions if there is a perceived risk of privacy 
breach. Anecdotally, healthcare staff often expressed concern about the privacy of 
certain workplace surveys they are asked to take, such as employee satisfaction 
surveys, even when they are reassured of the anonymity of the survey. During 
interviewer-administered surveys, responders may alter answers based on the 
perceived expectations and norms of the interview. For example, a participant would 
be less likely to express negative attitudes towards obese individuals if an obese 
individual were administering the survey. Bias may also affects interviewers, who may 
skip questions they feel uncomfortable asking. To decrease this effect, sensitive 
questions could be answered in private and sealed in an envelope before being given 
to the interviewer, thereby assuring a higher degree of privacy. Social desirability bias 
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may be affected by bystanders, especially if the study participant does not want to 
share the information. An example of this would be asking a teen about birth control 
in front of their parents, or asking about sexually transmitted disease in front of a 
spouse or significant other. Other methods to decrease social desirability bias would to 
neutrally word questions to minimize concerns on how answers would be judged, or to 
embed sensitive questions among unoffending questions related to the topic of 
interest. Another way to minimize bias would be to increase the subjective cost of 
misreporting by making the participant believe that there was a method being 
employed that would detect misreporting, such as with a lie detector. Social 
desirability bias may also be decreased by having the participant act as an informer on 
others behavior or attitudes, or by use of someone who knows the target of the study 
well. This may work because the participant is not expressing their own beliefs, 
attitudes, or behaviors. The informant method may not be effective if there is a 
perceived lack of privacy and the participant has fear of repercussions. Another 
method includes the randomized response technique where respondents use a 
randomizing device, such as a die or coin, to decide which questions they will answer. 
The interviewer does not know which question was selected by the participant or their 
response. Also, the unmatched count technique could be used. Participants are divided 
into two groups, where one group answers a list of non-sensitive questions and the 
other answers the same list plus the sensitive questions. Questions that participants 
answered “Yes” to would be counted and that number reported to the interviewer. 
Another method that may be used to decrease social desirability bias would be 
to include a social desirability bias scale within a questionnaire, for example Latner et 
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al. (2008) described the use of the Marlowe-Crowne Social Desirability Scale when 
measuring for bias toward obese, homosexual, and Muslim individuals. A higher score 
on the scale would indicate that a participant may be more likely to under report 
negative attitudes. Based on the score, researchers would have the opportunity to 
discard the data, adjust the data to account for the bias, or merely recognize that social 
desirability bias was a factor within the study and mention it as a limitation. 
While the presence of stigma is apparent from studies of obese individuals, the 
evidence that stigmatization occurs is less conclusive from studies of healthcare 
providers. It is difficult to assess stigma directly from healthcare providers because of 
social desirability. Explicit measures of bias are difficult to obtain because subjects 
may be reluctant to report negative attitudes. It is possible to indirectly measure the 
presence of bias based on measuring the results of the bias. There is an association 
between attitude and behavior and the quality of healthcare obese patients receive, for 
example less screenings for mammography or Pap smear (Ǿstbyte et al., 2005) or the 
absence of weight loss counseling (Tsai & Waden, 2009). Measurement of these 
healthcare inequalities would provide a way to identify the presence of stigmatization 
while decreasing the effect of social desirability. The issue of privacy is not an issue 
since individual healthcare providers are not directly observed or questioned. 
There are several pros and cons to doing studies that link healthcare outcomes 
to attitude and biases. Biases, such as social desirability, associated with individuals 
responding to surveys or interviews would be eliminated. Researchers would be 
studying what was documented and not directly studying healthcare providers. Studies 
can be done retrospectively potentially giving the researcher access to more data. If 
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more data is required, researchers can look back over a broader period. This would be 
easier, for example, than trying to recruit more participants to take a survey. There are 
less ethical issues related to human subjects, such as ensuring confidentiality and the 
need to obtain informed consent, in retrospective record reviews. Such studies would 
be measuring actual healthcare outcomes to determine the presence and effect of bias 
rather than the results of an experiment. These studies can find associations between 
variables. The strength and direction of the relationships can be determined, opening 
the way for further study and possibly the determination of causative factors. 
The cons of using this type of study are that it would measure an association, 
which would not demonstrate that obesity bias is a causal factor in obese patients 
receiving less pain medication and that many be other unknown factors may be 
affecting pain medication administration besides bias. For example, a patient may 
have other health issues that are causing increased pain and results in increased pain 
medication administration, or possibly the patient has a higher tolerance for pain, or 
other non-medication pain relief are being used. Another con related to doing these 
studies retrospectively is that the researcher is relying on the accuracy of the data. 
Anecdotally, healthcare providers do not consistently paint a vivid clinical picture 
with their documentation. Patient information is often missing, either in error or 
because it was never assessed. 
Chapter Summary 
 The concept of stigma and its presence in healthcare was explored. Within 
healthcare, obesity is a condition of excess adipose tissue that is stigmatized. There 
were few studies found that examined obesity stigma in healthcare, although it has 
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been described in relation to other healthcare conditions, such as HIV/AIDS, mental 
illness, illicit drug use, epilepsy, and smoking. Obesity stigma has multiple 
consequences on healthcare outcomes, both from the patient perspective (e.g., 
decreased self-esteem, healthcare avoidance, etc.) and from a healthcare provider 
perspective (fewer referrals for screenings, less time spent with the patient, etc.). 
Selection of pain medication administration was based on the findings of the effect the 
presence of stigma has on patients receiving less medication. Pain medication 
administration has been studied in other stigmatized groups, but has not been studied 
in regards to obesity stigma. Pain medication was also selected in order to reduce the 
effects of social desirability. After review of multiple theoretical frameworks 
associated with the study of stigma, symbolic interaction was selected for this study. 
The selection was based on the frameworks alignment with other studies that explored 
the meaning individuals held regarding obesity and how it affected attitude. 
 Following exploration of the concept and theoretical framework, the electronic 
medical records related to patient demographics, ordering, and medication 
administration were queried. The measurement of dependent and independent 
variables is described in Chapter Three. Also described in the next chapter are sample 
selection, data analysis, and ethical consideration. 
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CHAPTER 3 
 
METHODOLOGY 
 
Treatment of pain has been used as an indicator of bias/stigmatization among 
healthcare providers in several studies (Sabin & Greenwald, 2012; Mills et al., 2011; 
Burgess et al., 2008; Pletcher et al., 2008), was used in this study. Undertreated post-
operative pain is associated with negative healthcare outcomes such as longer hospital 
stays, missed or shortened physical therapy sessions, and less ability to ambulate 
(Morrison et al., 2003). The relationship of pain treatment to obesity stigma has not 
been studied, but as described in the previous section has been studied with other 
stigmatized groups. 
Research Questions 
This quantitative study was designed to answer the following research questions: 
1. What is the difference in the total morphine equivalent dose of post-surgical 
pain medication administered between normal weight, overweight, and obese 
(Class I, II, and III) (World Health Organization, 2014) adult non-bariatric 
surgery patients? 
2. What is the relationship between pain medication ordered and administered 
and the BMI of adult non-bariatric surgery patients? 
3. What is the relationship between patients’ BMI and the receipt of post-surgical 
pain medication, when accounting for race, gender, age, insurance status, 
presence of psychiatric diagnosis, and pain score during hospitalization?  
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Design 
This study used a retrospective chart review to compare pain treatment among 
normal weight, over-weight, and obese patients as a measure of stigma. This design 
supported the intent of the study, which is to examine the differences in pain 
medication administration based on BMI, the relationships of pain medication 
ordering (as entered by the physician) and administration (as documented by the 
nurse) between different categories of BMI, and if there is a relationship between BMI 
and the amount of pain medication administered. 
Sample 
The sample was obtained through Information System (IS) query of the 
hospital system data warehouse, which contains data from electronic medical records 
from three hospitals and has been used by the healthcare system going back to 1993. 
The IS analyst employed through the hospital system from where the data was taken 
was given specific inclusion and exclusion criteria to extract the data. 
Inclusion criteria for the study were adult patients, 18 years of age, who must 
have been specifically admitted for a surgical procedure. Patients who were admitted 
for bariatric surgery, such as gastric bypass or gastric banding surgery, or were 
admitted for medical reasons, but ended up needing surgery, were excluded from the 
study. The reason for excluding bariatric surgery was that  prior studies have described 
that patients who were considered at fault for their obesity were more likely to 
generate negative attitudes from study participants than patients that were described as 
not being responsible for their obesity, such as in patients with thyroid conditions 
(Dejong, 1980). Also, it was possible that nurses working in the specialty of bariatric 
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surgery may display less bias related to an increased exposure to obese patients. 
Patients who were admitted to the hospital for medical reasons were excluded because 
their pain may have been influenced by factors other than surgery. Patients undergoing 
bariatric surgery could be considered as taking responsibility for their weight and 
taking action, therefore may experience less stigmatization than non-bariatric patients. 
Underweight patients were excluded from the study since being underweight may be 
associated with other healthcare issues that may impact pain during hospitalization. 
Patients who had patient-controlled analgesia ordered in the electronic medical record 
by a licensed independent practitioner during the post-operative period were excluded 
since they administer their own pain medications and nurses do not. 
Certain variables were measured to control for the effects of stigma against 
other groups documented in the literature, such as age, race, gender, socioeconomic 
status (inferred from insurance status), and psychiatric diagnosis. Also, data was 
collected in order to ensure the proper sample. For this study, patients being 
hospitalized for other reasons than surgery were excluded. Therefore admission 
diagnoses that were surgery-related were necessary. Comparing the date of admission 
to the procedure date also helped in sampling to ensure that patients were hospitalized 
for surgery and not for other reasons. Patients selected were admitted on the same day 
as their surgery. The type of surgical procedure was recorded in order to exclude 
bariatric surgery patients. It was also important to identify discharge date. Patients 
discharged on the same day were excluded from the study as their surgery would have 
minimal interactions with healthcare professionals and pain medication administration 
would be strictly limited to the immediate surgical recovery period. 
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Patients were selected from a healthcare system that includes three tertiary, 
acute-care hospitals that provide services to Rhode Island, Massachusetts, and 
Connecticut. In 2013, 14,884 inpatient surgeries were performed within the system. 
The sample was obtained from the historical database system, which files extend back 
to 1993. Equal numbers of patients were selected for the normal weight, overweight, 
obese I, obese II, and obese III groups, starting with December 31, 2013 and went 
back temporally. The final sample consisted of patients who had surgery from January 
1, 2013 through December 31, 2013. It was important that the sample be acquired 
prior to 2014, since the use of insurance status as an indicator for socioeconomic status 
would not have been reliable due to the provision in the Affordable Care Act that all 
Americans have access to affordable health insurance options. 
A power analysis was performed using SPSS Power 3. The power analysis for 
a one-way, fixed effects analysis of variance with 5 levels (normal weight, overweight, 
obese class I, obese class II, and obese class III) was performed.  The outcome was 
that 365 cases per level for a total of 1825 cases were needed.  The criterion for 
significance (alpha) was set at 0.05.  The analysis of variance is non-directional (i.e. 
two-tailed) which means that an effect in either direction will be interpreted.  For 
analysis of variance the effect size (f) was 0.10, which yielded a power of 0.95.  A 
small effect size for BMI was selected because there were no previous studies 
conducted related to BMI and pain medication administration from which effect size 
could be inferred. The sample was obtained from patients having surgery during 2013. 
Data was de-identified by the Information System (IS) staff prior to delivery for data 
analysis and each patient was assigned a unique ID number. Variables in the study 
 38 
 
included age (continuous), gender (categorical), race (categorical), BMI (continuous 
and categorical), insurance status (categorical), psychiatric diagnoses during 
admission (categorical),  pain medication frequency and dose ordered, frequency and 
dose of pain medication administration by the nurse, type of drug administered 
(narcotic/non-narcotic), and pain score during hospitalization (categorical). After 
removal of duplicate cases and cases with no height or weight entry, a random 
sampling  of BMI categories that contained greater than 365 cases was performed to 
achieve the number determined by the power analysis. 
Measurement of Dependent Variables 
 Pain Medication Administration. Data related to pain medication 
administered during the first (postoperative day one) and second (postoperative day 
two) 24-hour period, for a total of 48 hours after surgery, was collected. This included 
the number of times that intravenous narcotics, oral narcotics, and non-narcotics were 
administered, as well as the average dose during each 24-hour period. The electronic 
medication administration records for the sample were examined to determine which 
pain medications were administered and are described in Table 2. Pain medications 
were identified from a list extracted from the electronic medical record data based and 
if any of these medications that were administered during postoperative day one or day 
two the patients were included in the study. Intravenous narcotics of interest during 
review of the medical record included morphine, hydromorphone, fentanyl and 
meperidine. Non-intravenous narcotics included hydrocodone and oxycodone. Non-
narcotics included acetaminophen, ibuprofen, ketorolac, and diclofenac. Since it is 
difficult to do an overall comparison of pain medication due to differing amounts, 
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strengths, and doses used between the IV and PO pain medications, narcotic 
equivalency used in this study. This method has been used in other studies to facilitate 
analysis between different opioid medications (Olson, Hanson, & Michaud, 2003, 
Fillingim, Doleys, Edwards, & Lowery, 2003, Allen, et al., 2003). Conversion tables 
should be taken as approximations and not as absolute doses. Tables often describe 
different conversion and dose calculations and caution is prescribed when using these 
in actual clinical practice (Shaheen et al., 2009). The conversion table used for this 
study was based on information from GlobalRPh (2015). Narcotic equivalency is an 
approximation and compares a given oral or intravenous pain medication dose to the 
equivalent dose of oral morphine and approximations used in this study are listed in 
Table 3. For example, oxycodone is 1.5 times stronger than oral morphine; therefore 
10 mg of oxycodone would be equivalent to approximately 15 mg of oral morphine. 
Conversions were done for each medication and added together to determine the total 
equivalent dose of oral morphine that each patient received during the first and second 
24-hour period after surgery. 
Measurement of Independent Variables 
 Age. Age was measured in years and was selected as a variable because of its 
potential effect on the treatment of pain.  Older adult patients have been shown to 
receive less pain medications than younger patients (Jones, Johnson & McNinch, 
1996), therefore it was important to account for age as a potential bias contributing to 
the amount of medication received by the patient. 
Gender. Gender was measured as male or female. This variable was chosen 
because the described differences in the experience of pain between men and women. 
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It was necessary to measure gender to account for bias since women were less likely to 
be taken seriously, receive adequate treatment for pain, have pain ascribed to 
psychiatric causes, and be treated less aggressively. 
Race. Race, as valued within the electronic medical record, was described as 
White, Black, Asian, and All Other. This variable was selected because other studies, 
described within the literature review, have described race as a bias related to 
decreased administration of pain medications. 
BMI. Body Mass index (BMI) was calculated from recorded height and weight 
on admission. BMI is an indicator of body fatness and is calculated by dividing weight 
(kg) by height squared (m
2
). BMI is described by the Centers of Disease Control and 
is used to classify individuals into the different weight categories used in this study; 
normal (18.5 – 24.9) and overweight (25 – 29.9) (Center for Disease Control and 
Prevention, 2015). Definitions of obesity used were broken down by the World Health 
Organization as Class I (30 – 34.9), Class II (35 – 39.9), and Class III  (≥40) (World 
Health Organization, 2014). In this study, the difference in pain medication 
administration was compared between normal weight patients and overweight, obese 
class I, obese class II, and obese class III patients. Also, the relationship between pain 
medication administration and BMI was explored. 
Insurance Status. Insurance status included private insurance, Medicare, 
Medicaid, Worker’s Compensation, or no insurance categories. This variable was used 
as an indicator for socioeconomic status and has been used in multiple studies 
(Vijayakumar, et al., 1995, Hong, Baumann, & Boudreaux, 2007) and has been 
perceived as a reason for discrimination during healthcare provision. Use of insurance 
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status is not an exact measure of socioeconomic status, but status may be inferred. For 
example, Medicare is offered to low income individuals.  
Psychiatric Diagnosis. Presence of psychiatric diagnosis was positive if any 
psychiatric diagnosis listed in the Diagnostic and Statistical Manual of Mental 
Disorders exists for the patient during the hospitalization. Mental illness has been 
described as a stigmatized condition and therefore it was important to account for it 
during this study.  
Pain Score. Patients with higher pain scores receive more pain medication, so 
it was important to account for pain score to understand if less pain medication is 
administered to obese patients. Pain was assessed on a scale of 0-10, with 0 being no 
pain and 10 being the worst possible pain ever. This scale is a subjective measure of 
pain that is reported to the nurse by the patient. Pain score was entered by the nurse 
into the medication administration as ordinal values and were described as mild (1-2), 
moderate (3-4), moderate/severe (5-7), and severe (8-10).  
Data Analysis 
 IBM SPSS Statistics 23 was used to analyze data for this research study. Data 
for the first research question was analyzed using one-way ANOVA. The dependent 
variable was pain medication administration and the independent variable was BMI 
category. Pain medication administration was divided into total narcotic equivalency 
doses, and the total dose of intravenous and oral narcotic and non-narcotic medications 
given during a first and the second day postoperative period. The groups used were the 
BMI classifications of normal weight, overweight, and obese class I, obese class II, 
and obese class III. 
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In addressing the second research question, the number of intravenous and oral 
narcotic, and non-narcotic medications ordered and administered were compared 
between the five BMI categories. A chi-square test was used to determine if there was 
a significant difference between expected (ordered by a licensed independent 
practitioner) and observed (administered by the nurse) medication, dose, and 
frequencies. 
  Regression analyses were used to address the third research question. Simple 
linear regression was used to determine the relationship between the total morphine 
equivalent dose and BMI. Separate analyses were performed for the dose on 
postoperative day one and day two to determine if there were any differences in the 
relationship between days. Hierarchical linear regression was used to determine the 
relationship between dose on postoperative day one, and then the dose on day two, and 
BMI after controlling for other factors related to stigma and to the amount of pain each 
patient reported. The independent variables for each regression analysis will be BMI 
(continuous), race (categorical), gender (categorical), age (continuous), insurance 
status (categorical), presence of psychiatric diagnosis (categorical), and average pain 
score during hospitalization (categorical). Dummy variables were created for each of 
the categorical variables within the regression analysis. 
Ethical Considerations 
 Institutional Review Board approval was obtained from both the hospital 
system (Appendix A) and the University of Rhode Island (Appendix B) prior to 
conducting this study. Consent was not obtained because this was a retrospective chart 
review using de-identified data, posing no more than minimal risk, not affecting the 
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rights and welfare of the subjects, and the consent would have been the only 
documentation linking the study to the patient. A waiver would not adversely affect 
the rights and welfare of the subjects since the study was a retrospective chart review 
and all identifiers was removed. The sample size required was large and including 
only those samples/records/data for which consent can be obtained would prohibit 
conclusions to be drawn or bias the sample such that conclusions would be skewed. 
Also, since the potential time period being looked at was ten years, the proportion of 
individuals likely to not be able to be contacted due to having relocated or died would 
be a significant percentage of the subject population and the research results may not 
be meaningful and lose statistical power. All data points were supplied by IS query 
and did not contain one of the 18 HIPAA identifiers (U.S. Department of Health and 
Human Services, 2012). All data points were supplied by IS query and were de-
identified by the Information System (IS) staff prior to delivery for data analysis and 
each patient was be assigned an identification (ID) number. Chart review was not 
performed remotely. The study did not include the use of investigational drugs, 
devices, or psychological interventions. Breach of confidentiality would have been the 
only possibility, but was prevented by the use of de-identifying the data. The potential 
benefits to research subjects as a result of the study would be the identification of 
obesity stigma as a problem as related to post-operative pain medication 
administration, creating an impetus to develop interventions aimed toward healthcare 
providers, thereby improving outcomes and the quality of care.
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CHAPTER 4 
 
FINDINGS 
 
Data received from IS staff contained 56,384 observations with 2734 unique 
cases that spanned 1/1/2013 to 12/31/2013. Multiple observations occurred for 
individual cases due to several ICD-9 procedure codes/descriptions being listed for a 
single surgical visit. Other than the procedure, data such as age, BMI, race, insurance 
status, psychiatric diagnosis, and pain score was identically entered for each duplicate 
observation. Procedures were separated out into a different dataset and duplicate 
observations were removed. Cases were also removed that contained no height or 
weight entries, that had no pain medication documented during the first 48 hours, or 
indicated patients on a ventilator. These ventilator patients were removed from the 
data set because it was found that they only had intravenous sedation medication, to 
maintain a state of unconsciousness, and no pain medication administrations 
documented during postoperative day one or two. A total of 1939 cases remained. The 
normal, overweight, and obesity class I groups had an excess of cases, from which a 
random sampling was performed to achieve 365 cases. With this initial exclusion of 
cases, the obesity class II and III groups contained less than 365 cases. The final data 
set contained a total of 1704 unique cases, with 21.4% (n=365) normal weight, 21.4% 
(n=365) overweight, 21.4% (n=365) obesity class I, 17.1% (n=291) obesity class II, 
and 18.7% (n=318) obesity class III individuals. BMI scores ranged from 18.5 to 
185.9 (M = 33.1, SD = 11.1). A total of 4203 procedures were performed on the 1704 
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patients. The procedures, and their frequencies of being performed, are listed in Table 
4. The table lists ICD 9 procedure code descriptions that were performed on more than 
one patient. The descriptive statistics for each variable based on BMI are listed in 
Table 5. 
Dependent Variable 
 Pain medications documented as given during the first 48 hours after a 
procedure were hydromorphone, morphine, fentanyl, meperidine, oxycodone, 
ketorolac, acetaminophen, and ibuprofen. A breakdown of frequency can be seen in 
Table 6, which displays the pain medication that were listed as being administered, as 
well as the number of patients that the medication was given to. Hydromorphone was 
a common pain medication during the first 48 hours after surgery and was given to 
86.7% (n=1478) of patients during the first 24 hours and 18.2% (n=310) during the 
second 24 hours. Descriptive statistics in Table 7 describe the range of doses for each 
pain medication administered. These doses were used to calculate the total oral 
morphine equivalency dose given. During postoperative day one, the minimum oral 
morphine equivalent dose was 1.25 mg and a maximum of 1015 mg (M = 21.2, SD = 
35.6). The minimum dose during the postoperative day two was .63 mg and a 
maximum of 525 mg (M = 20, SD = 30.5). Table 8 breaks down the descriptive 
statistics for total morphine equivalent dose of pain medication by BMI category. 
Independent Variables 
 Age. The age of the study population ranged from 18 to 96 (M = 57.1, SD = 
15.9). Descriptive statistics for age within each BMI category are listed in Table 9. 
There was a significant difference in the mean age of each group, F (4, 1699) = 32.9, p 
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< .0001). Post hoc comparisons (Table 10) using the Tukey HSD test indicated that the 
mean age for normal BMI (M = 60.1, SD = 17.9) was significantly greater than the 
mean age of the obesity class II (M = 55.2, SD = 15.6) and obesity class III (M = 49.1, 
SD = 13.9) groups. The mean age of the overweight group (M = 61, SD = 15.1) was 
also significantly greater from the mean age of the obesity class II and III groups. The 
mean age of the obesity class III group (M = 49.1, SD = 13.9) was significantly less 
than all other groups.  
 Gender. There was a significant relationship between gender and the five BMI 
groups, X
2 
(4, N= 1704) = 57.3, p <.0001. There were a higher proportion of females 
than males in the obesity class III group, which consisted of 30% male (n= 94) and 
70% female (n = 224) (Table 11). The obesity class III group had a larger proportion 
of females than all the other BMI groups and the overweight group had a larger 
proportion of males than all the other BMI groups (Table 12). 
 Race. There was no relationship between race and the five BMI groups 
although overall, a vast majority of cases, 86.9% (n=1481) listed a race of “White”. 
The other race categories made up far less of the total population, with 7.2% “Black”, 
.3% “Asian”, and 5.5% “All Other”.  
 Insurance Status. There was a significant relationship between insurance 
status and the five BMI groups, X
2 
(16, N = 1704) = 33, p = .007. There were a higher 
proportion of overweight (.22), obesity class I (.23), and obesity class III patients (.2) 
with private insurance than the normal BMI group (.19) (Table 13). 
 Pain Scores. Pain scores were only recorded in 48% (n=824) of cases and 
overall frequencies of mild, moderate, moderate/severe, and severe pain are listed in 
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Table 14. There was a significant relationship between BMI category and moderate 
pain, X
2
 (4, N = 1704) = 12.6, p = .01. The overweight group had a higher proportion 
of reported moderate pain (.26) than the obesity class II group (.13), t (654) = 3.12, p = 
.002 (Table 15). There were no other significant differences in moderated pain 
between the BMI groups. There was no significant relationship between BMI and mild 
pain. No groups had a pain score of moderate/severe or severe recorded. 
Research Question 
 Research Question One. What is the difference in the total morphine 
equivalent dose of post-surgical pain medication administered between normal weight, 
overweight, and obese (Class I, II, and III) adult non-bariatric surgery patients? 
 Data for the total postoperative day one and postoperative day two oral 
morphine equivalent dose of pain medication contained several extreme outliers which 
were removed prior to performing an analysis. These outliers showed dose values 
approaching 1015 mg. High doses such as these could harm patients and were most 
likely documented in error. Doses greater than 120 mg were removed because many 
dosing guidelines recommend a maximum morphine equivalent dose of 120 mg per 
day (Franklin et al., 2012, Braden et al., 2010). These high doses may have been 
entered in error, or represented patients with high tolerance to narcotics. A significant 
difference was not found among the BMI groups related to total doses greater than 120 
mg. Descriptive statistics of the study sample after removal of outliers are listed in 
Table 16. 
Histograms and Q-Q plots for postoperative day one and day two values 
demonstrated a positive skew (Figures 1 through 4) and were transformed to 
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approximate a normal distribution. A Box-Cox transformation (Osborne, 2010) was 
used to obtain normally distributed values for postoperative day one and day two total 
morphine equivalent dose. The value of lambda that yielded the smallest value for 
mean square residual was 0 for the postoperative day one total morphine equivalent 
dose and for the postoperative day two total morphine equivalent dose. Therefore, a 
natural logarithmic transformation was performed on the two variables. After 
transformation, both variable histograms and Q-Q plots (Figures 5 through 8) better 
approximated a normal distribution, although the assumptions of normality and 
homogeneity of variance were not met. The Shapiro-Wilks and Levine statistics 
demonstrated a significant difference from normality and from homogeneity of 
variances and therefore the Brown-Forsythe robust test of means was used determine 
the difference in mean between the BMI categories (Brown & Forsythe, 1974). 
Games-Howell’s procedure was used for post hoc multiple comparisons due to the 
heterogeneity of variances (Keselman & Rogan, 1978). A one-way ANOVA was 
performed with the log-transformed total postoperative day one oral morphine 
equivalent dose of pain medication dependent variable and the BMI classification 
independent variable and there was a significant difference in the mean dose of pain 
medication given for each of the BMI categories, F (4, 1468) = 2.72, p = 0.03. Games-
Howell’s post hoc test (Table 17) revealed that the geometric mean of the total 
postoperative day one oral morphine equivalent dose for overweight individuals was 
significantly different (p = .004) and 1.22 times as much as for obesity class III 
individuals (95% CI: 1.05 to 1.42 times as much). While there was not a significant 
difference with the other groups, there was a downward trend in dose between the 
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overweight group and the obesity class I and II groups (Figure 9). The postoperative 
dose for the normal BMI group was 1.1 times as much as the obesity class I group, and 
1.01 times as much as the obesity class II group. There was not a significant difference 
in dose between the normal BMI and all other groups. 
 A one-way ANOVA was performed with the log-transformed total 
postoperative day two oral morphine equivalent dose of pain medication dependent 
variable and the BMI classification independent variable. The analysis resulted in no 
significant difference in mean dose of pain medication given for each of the five BMI 
categories. 
 Research Question Two. What is the relationship between pain medication 
ordered and administered and the BMI of adult non-bariatric surgery patients? 
Two-way contingency table analyses were conducted to evaluate if pain 
medication ordering and administration were related to BMI. There were two separate 
electronic medical record systems used to for ordering and medication administration 
and the dose and frequency were not documented in equivalent units between each 
system. The medication ordering system used “Units” while the medication 
administration system used “mg”. Also, documentation of medication administration 
tended to be grouped by the nurse. Multiple doses were grouped into one dose that 
would span an eight-hour shift. Because of this the comparison between 
dose/frequency ordered and administered to determine if they were related was not 
possible. 
The two variables were pain medication ordered and administered (Not 
Ordered – Not Administered, Not Ordered – Administered, Ordered – Not 
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Administered, Ordered – Administered) and BMI (Normal, Overweight, Obesity Class 
I, Obesity Class II, Obesity Class III). Pain medication ordered/administered and BMI 
were found to be significantly related for hydromorphone, X
2
 (8, N=1680) = 23.03, p = 
.003, morphine, X
2
 (12, N=1682) = 46.77, p < .0001, meperidine, X
2
 (8, N=1682) = 
29.93, p < .0001, oxycodone, X
2
 (12, N=1682) = 21.1, p = .05, and acetaminophen, X
2
 
(12, N=1682) = 49.2, p < .0001. There was a borderline significant relationship with 
ketorolac, X
2
 (8, N = 1682) = 15.22, p = .055. A significant relation was not found 
between fentanyl ordering/administration and BMI. Follow-up pairwise comparisons 
were conducted to evaluate the difference among these proportions. Tables 18 and 19 
show the number and proportion results of the crosstabulation. Independent sample t-
tests were performed for crosstabulation table columns. All t-tests had a significant 
result for Levine’s test for equality of variances; therefore the value when equal 
variances are not assumed was used. The results of the t-tests are listed in Table 20. 
While there were significant differences in proportion found, there were none found 
that suggest that the higher BMI groups consistently had smaller proportions for 
ordering and administration when compared to the lower BMI groups. 
Hydromorphone. In the overweight BMI category, the proportion of 
hydromorphone ordered and administered (.96) was greater than the proportion not 
ordered and not administered (.006), t (986) = 7.37, p < .0001. Overweight individuals 
had a higher proportion of hydromorphone ordered and administered (.23) than the 
normal (.21), t (673) = 2.55, p = .01, obesity class I (.21), t (666) = 2.78, p = .006, and 
obesity class II (.16), t (481) = 3.62, p < .0001, categories. The obesity class III (.19) 
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category had a higher proportion ordered and administered than the obesity class II 
(.16) category, t (557) = 2.16, p = .03.  
Morphine. The proportion of morphine not ordered and not administered (.74) 
was greater than the proportion ordered and administered (.21) in the overweight 
category, t (1127) = 4.35, p < .0001. The overweight, t (585) = 5.69, p < .0001, obesity 
class I, t (610) = 3.16, p = .002, and obesity class III, t (591) = 4.33, p < .0001, 
categories had higher proportions (.25, .22, and .20 respectively) of morphine that was 
not ordered and not administered than obesity class II (.14). The proportions of the 
overweight (.25), t (720) = 4.34, p < .0001, and obesity class III (.20), t (677) = 2.94, p 
= .003, groups for morphine not ordered and not administered were greater than the 
proportion of the normal BMI group (.20). The proportion of morphine that was 
ordered and administered for the normal BMI category (.25) was greater than in the 
overweight (.15), t (710) = 4.05, p < .0001, and the obesity class III (.15), t (680) = 
2.77, p = .006, categories.  
Meperidine. In the overweight category, there was a higher proportion of 
meperidine not ordered and not administered (.98) than ordered and administered 
(.01), t (67) = 3.78, p < .0001. The proportion of meperidine not ordered and not 
administered was higher among overweight (.22) than obesity class II individuals 
(.16), t (427) = 4.31, p < .0001.There was a higher proportion of medication ordered 
and administered among obesity class II individuals (.39) than overweight (.07), t 
(362) = 3.93, p <.0001, and obesity class I (.14), t (429) = 3.10, p = .002. 
Oxycodone.  Within the obesity class II category, the proportion of oxycodone 
ordered and administered (.24) was greater than medication not ordered and not 
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administered (.15), t (282) = 2.80, p = .006.The proportion of medication not ordered 
and not administered (.61) was greater than ordered and not administered (.26) among 
obesity class III individuals, t (1185) = 2.67, p = .008. The obesity class III group had 
a higher proportion (.21) of oxycodone not ordered and not administered than the 
obesity class II group (.15), t (600) = 3.06, p = .002. 
Ketorolac. Within the obesity class III group, the proportion of ketorolac that 
is not ordered and not administered (.84) was greater than the proportion ordered and 
administered (.12), t (448) = 2.87, p = .004. The obesity class I group had a greater 
proportion of ketorolac ordered and administered (.26) than the obesity class III group 
(.13), t (675) = 3.21, p = .001.  
Acetaminophen. There is a greater proportion of acetaminophen not ordered 
and not administered in the obesity class III category (.33) than the proportion ordered 
and administered (.09), t (805) = 4.34, p < .0001. Also within the same BMI category, 
the proportion of medication ordered but not administered (.58) was greater than the 
proportion ordered and administered (.09), t (816) = 5.99, p < .0001. The overweight 
category had a smaller proportion of medication ordered and administered (.27) than 
not ordered and not administered (.31), t (590) = 3.34, p = .002, or ordered and not 
administered (.42), t (482) = 4.45, p < .0001. The normal (.26), t (646) = 5.08, p < 
.0001, overweight (.31), t (631) = 6.35, p < .0001, and obesity class I (.20), t (666) = 
3.47, p < .0001, categories had a greater proportion of medication ordered and 
administered than the obesity class III category (.09). The overweight category also 
had a greater proportion ordered and administered (.31) than the obesity class II 
category (.14), t (654) = 3.70, p < .0001. Obesity class III has a greater proportion of 
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medication ordered but not administered (.22) than the normal (.21), t (669) = 270, p = 
.007, and overweight (.18), t (667) = 4.01, p < .0001, categories.  
 Research Question Three. What is the relationship between patients’ BMI 
and the receipt of post-surgical pain medication, when accounting for race, gender, 
age, insurance status, presence of psychiatric diagnosis, and pain score during 
hospitalization? 
 Separate analyses were performed for the total oral morphine equivalent dose 
during the first 24-hours (postoperative day 1) and for the second 24 hours 
(postoperative day 2) after surgery. Simple linear regression was used to determine the 
relationship between the independent variable total postoperative oral morphine 
equivalent dose and the dependent variable BMI. Hierarchical multiple regression 
analysis was then performed to determine the relationship after controlling for other 
factors related to stigma such as age, gender, race, insurance status, psychiatric 
diagnosis, and also factors related to the amount of pain each patient reported (pain 
score).  
Total postoperative day one morphine equivalent dose. Extreme outliers were 
found that had cutoff values for Cook’s Distance greater than .0024 (Fox, 1991) and 
Leverage values greater than .0023 (Montgomery, Peck & Vining, 2012). In 
examining the outliers, BMI was found to be greater than 151 in four of the cases. 
While the weight of these patients appeared to be realistic adult weights, 55 kg – 87 kg 
(121 – 192 lbs.), the heights were all measured as less than .724 m (2.37 ft.). Most 
likely the height values were entered in error and therefore these four values were 
removed prior to all regression analyses. 
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Simple linear regression assumptions. A simple linear regression was 
performed and the assumption of normality of residuals was not met, as shown in 
positively skewed histogram (Figure 10) and non-linear P-P plot (Figure 11). Also, the 
assumption of homogeneity of variances (homoscedasticity) was not met as seen by a 
non-random distribution of points on a scatterplot of studentized residuals against the 
predicted value (Figure 12). The variances appeared to increase as a function of the 
predicted value. 
After performing a natural log transformation of the total postoperative day 
one oral morphine equivalent dose, heteroscedasticity was still apparent after 
transformation (Figure 13), therefore the independent variable BMI was also 
transformed using a natural logarithmic transformation. After transformation of BMI, 
the scatterplot of studentized residuals against predicted values (Figure 14) 
demonstrated a relatively random display of points that were spread fairly constant 
over the range of values of the total postoperative day one oral morphine equivalent 
dose provided evidence of homogeneity of variances. Also, the assumption of 
normality of residuals was reasonable based on a normally distributed histogram 
(Figure 15) and linear P-P plot (Figure 16). The scatterplot of total oral morphine 
equivalent dose and BMI indicated that the assumption of linearity was reasonable 
with point roughly symmetrical in distribution around the fit line (Figure 17). Figure 
14 provided further evidence of linear relationship through a scatterplot of 
standardized residuals versus predicted values that demonstrated a random distribution 
of points distributed with roughly constant variance around the horizontal line. 
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The Durbin-Watson statistic was used to determine independence of errors, d = 
1.97, which was between 1.5 and 2.5 (Hutcheson & Sofroniou, 1999) and therefore the 
null hypothesis was not rejected and it could be concluded that the errors were not 
autocorrelated (Montgomery, Peck & Vining, 2012) and the assumption of 
independent errors was been met.  
 Simple linear regression model. The results of the simple linear regression 
suggested a significant relationship between the postoperative day one total oral 
morphine equivalent dose and BMI, F (1, 1622) = 5.6, p  = .018, and accounted for 
approximately .3% of the variance of the equivalent dose (R
2
 = .003, Adjusted R
2
 = 
.003). The total postoperative day one oral morphine equivalent dose was equal to 
3.32 + (-.184)(BMI) mg. Every one percent increase in BMI would result in a .18% 
decrease in pain medication administration on postoperative day one, p = .018, 95% 
CI [-.337, -.032]. 
Hierarchical multiple regression. Hierarchical multiple regression was 
performed to investigate the relationship between the total postoperative day one oral 
morphine equivalent dose and BMI, after controlling for other factors related to 
stigma, such as age, gender, race, insurance status, and presence of psychiatric 
diagnoses, and also controlling for level of pain. Table 21 contains descriptive 
statistics for variables used. 
Seventy-four extreme outliers were found that had large cut off values for 
Mahalanobis Distance, p < .001. Out of these, twenty-eight cases were highly 
influential and had high leverage with Cook’s Distances greater than .0024 and 
leverage values greater than .018. No clinical significance of the outliers was readily 
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apparent, therefore analyses were run first without removal of outliers and then after 
outliers had been removed to examine any differences or patterns. When all outliers 
were removed, Asian, Medicaid, and Workers Compensation patients were no longer 
accounted for within the sample. The moderate/severe and severe pain independent 
variables were not used in any of the regression analyses since there were no cases in 
the sample where the presence of moderate/severe or severe pain was reported. 
Hierarchical regression assumptions described with outliers intact. 
Preliminary analyses were conducted to ensure no violations of the assumptions of 
normality of variances, linearity, and homoscedasticity. The assumption of normality 
of residuals was reasonable based on a normally distributed histogram (Figure 18) and 
linear P-P plot (Figure 19). Evidence of linearity was provided by scatterplots of 
standardized residuals versus predicted values that demonstrated a random distribution 
of points that were distributed with a roughly constant variance  for the total model 
(Figure 20) and each of the continuous independent variables, age and BMI, in partial 
regression plots (Figures 21 and 22). 
Examination of the correlation matrix (Table 22) and the variable inflation 
factor (VIF) values for the independent variables suggested that multicollinearity was 
not an issue (Montgomery, Peck & Vining, 2012). There was little to low correlation 
between the independent variables. VIF values were all less than 10 (1.013 – 1.310). 
Most Eigenvalues were well above zero; however the values for moderate pain and 
BMI were close to zero (.042 and .002). The Condition Index for moderate pain was 
10.66 suggesting a weak to moderate degree a multicollinearity and the value for the 
log transformed BMI was above 30 (44.682) suggesting a high degree (Callaghan & 
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Chen, 2008). No evidence of multicollinearity was assumed since only one 
independent variable had large variance proportions corresponding to each large 
condition indices.  
The bivariate and partial correlations showed small but significant relations to 
total oral morphine equivalent dose and are shown in Table 23. As can be seen, BMI 
and age were negatively and significantly correlated, indicating that as BMI and age 
increase the amount of pain medication on postoperative day one decreased.  
Hierarchical regression model with outliers intact. In the first step of 
hierarchical multiple regression, twelve predictors were entered: age, gender, race 
(black, Asian, all other), insurance status (Medicare, Medicaid, Worker’s 
Compensation, no insurance), presence of psychiatric diagnosis, and level of pain 
(mild pain, moderate pain). There were no cases of patients reporting moderate to 
moderate/severe pain, therefore these variables were not entered into the regression 
equation. The prediction model for the morphine equivalent dose during postoperative 
day one was significant, F (12, 1568) = 5.4, p < .001, and accounted for approximately 
4% of the variance of the equivalent dose (R
2
 = .040, Adjusted R
2
 = .032). After entry 
of the natural log transformed BMI at step 2 the total variance explained by the model 
as a whole was 4.5% (R
2
 = .045, Adjusted R
2
 = .037), F (13, 1567) = 5.7, p < .001. The 
introduction of BMI explained an additional .6% of the variance in total dose, after 
controlling for age, gender, race (black, Asian, all other), insurance status (Medicare, 
Medicaid, Worker’s Compensation, no insurance), presence of psychiatric diagnosis, 
and level of pain (mild pain, moderate pain), R
2 
Change
  
= .006, F (1, 1567) = 9.66, p 
= .002. The regression coefficients are listed Table 24 and show that BMI was a 
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significant predictor in the model when controlling for the other variables. In the final 
model five out of thirteen predictor variables were statistically significant. Patients 
with a greater BMI received less postoperative day one pain medication, β = -.25, p = 
.002. While keeping all other variables constant, every one percent increase in BMI 
would result in a .25% decrease in pain medication administration on postoperative 
day one, 95% CI [ -.408, -.092]. Gender was a statistically significant predictor 
variable, β = -.142, p = .001, and being female would result in a 14.2% decrease in 
pain medication administration, 95% CI [-.223, -.061], keeping all other variables 
constant. Age was also a significant predictor of receiving less pain medication, β = -
.005, p < .0001. While keeping all other variables constant, every one year increase in 
age would result in a .5% decrease in pain medication, 95% CI [-.008, -.003] . 
Worker’s Compensation patients received 90.8% more pain medication and patients 
with a psychiatric diagnosis received 23.2% more, p < .0001, 95% CIs [.553, 1.283] 
and p = .001, [.092, .372] respectively when keeping all other variables constant. 
Hierarchical regression assumptions described with outliers removed. 
Preliminary analyses were conducted to ensure no violations of the assumptions of 
normality of variances, linearity, and homoscedasticity. The assumption of normality 
of residuals was reasonable based on a normally distributed histogram (Figure 23) and 
linear P-P plot (Figure 24). Evidence of linearity was provided by scatterplots of 
standardized residuals versus predicted values that demonstrated a random distribution 
of points displaying a roughly constant variance around the horizontal line for the total 
model (Figure 25) and each of the continuous independent variables, age and BMI, in 
partial regression plots (Figures 26 and 27). 
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Examination of the correlation matrix (Table 25) and the variable inflation 
factor (VIF) values for the independent variables suggested that multicollinearity was 
not an issue (Montgomery, Peck & Vining, 2012). There was little to low correlation 
between the independent variables. VIF values were all less than 10 (1.013 – 1.291). 
Most Eigenvalues were well above zero; however the values for moderate pain and 
BMI were close to zero (.041 and .002). The Condition Index for moderate pain was 
10.68 suggesting a weak to moderate degree a multicollinearity and the value for the 
log transformed BMI was above 30 (44.581) suggesting a high degree (Callaghan & 
Chen, 2008). No evidence of multicollinearity was assumed since only one 
independent variable had large variance proportions corresponding to each large 
condition indices.  
The bivariate and partial correlations showed small but significant relations to 
total oral morphine equivalent dose and are shown in Table 26. As can be seen, BMI 
and age were negatively and significantly correlated, indicating that as BMI and age 
increased the amount of pain medication on postoperative day one decreased.  
Hierarchical regression model with outliers removed. In the first step of 
hierarchical multiple regression, nine predictors were entered: age, gender, race 
(black, all other), insurance status (Medicare, no insurance), presence of psychiatric 
diagnosis, and level of pain (mild pain, moderate pain). The prediction model for the 
morphine equivalent dose during postoperative day one was significant, F (9, 1503) = 
3.73, p < .001, and accounted for approximately 2.2% of the variance of the equivalent 
dose (R
2
 = .022, Adjusted R
2
 = .016). After entry of the natural log transformed BMI at 
step 2 the total variance explained by the model as a whole was 2.8% (R
2
 = .028, 
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Adjusted R
2
 = .021), F (10, 1502) = 4.28, p < .001. Even with the outliers removed, the 
introduction of BMI continued to explain an additional .6% of the variance in total 
dose, after controlling for age, gender, race (black, all other), insurance status 
(Medicare, no insurance), presence of psychiatric diagnosis, and level of pain (mild 
pain, moderate pain), R
2 
Change
  
= .006, F (1, 1502) = 9.09, p = .003. The regression 
coefficients are listed Table 27 and show that BMI remained a significant predictor in 
the model when controlling for the other variables. In the final model four out of ten 
predictor variables were statistically significant. Patients with a greater BMI received 
less postoperative day one pain medication, β = -.25, p = .003. While keeping all other 
variables constant, every one percent increase in BMI would result in a .25% decrease 
in pain medication administration on postoperative day one, 95% CI [ -.409, -.087]. 
Gender was a statistically significant predictor variable, β = -.142, p = .001, and being 
female would result in a 14.2% decrease in pain medication administration, 95% CI [-
.224, -.059], keeping all other variables constant. Age was also a significant predictor 
of receiving less pain medication, β = -.005, p < .0001. While keeping all other 
variables constant, every one year increase in age would result in a .5% decrease in 
pain medication, 95% CI [-.008, -.002] . Patients with a psychiatric diagnosis received 
a 23.7% higher dose, p = .002, 95% CIs [.091, .384] when keeping all other variables 
constant. 
Total postoperative day two morphine equivalent dose. The four extreme 
outliers found with BMI greater than 151 were also removed in examining the 
postoperative day two morphine equivalent dose. These were most entered in error and 
therefore these four values were removed prior to the analysis. The mean BMI after 
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removal of the outliers was 32.8, SD = 9.01, with a minimum BMI of 18.5 and a 
maximum of 97.3. Fifty-five cases were highly influential and had high leverage with 
Cook’s Distances greater than .0024 and leverage values greater than .018. One 
extreme outlier was found that had large cut off values for Mahalanobis Distance, p < 
.001. No clinical significance of the outliers was readily apparent, therefore analyses 
were run first without removal of outliers and then after outliers had been removed to 
examine any differences or patterns. The moderate/severe and severe pain independent 
variables were not used in the regression analysis since there were no cases in the 
sample where the presence of moderate/severe or severe pain was reported. 
Simple linear regression assumptions. A simple linear regression was 
performed and the assumption of normality of residuals was not met, as shown in 
positively skewed histogram (Figure 28) and non-linear P-P plot (Figure 29). Also, the 
assumption of homogeneity of variances was not met as seen by a non-random 
distribution of points on a scatterplot of studentized residuals against the predicted 
value (Figure 30). The variances appeared to decrease as a function of the predicted 
value. 
After performing a natural log transformation of the total postoperative day 
two oral morphine equivalent dose, heterogeneity of variances was still apparent after 
transformation (Figure 31), therefore the independent variable BMI was also 
transformed using a natural logarithmic transformation. After transformation of BMI, 
the scatterplot of studentized residuals against predicted values (Figured 32) 
demonstrated a relatively random display of points that were spread fairly constant 
over the range of values of the total postoperative day two oral morphine equivalent 
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dose provided evidence of homogeneity of variances. Also, the assumption of 
normality of residuals was reasonable based on a normally distributed histogram 
(Figure 33) and linear P-P plot (Figure 34). The scatterplot of total oral morphine 
equivalent dose and BMI indicated that the assumption of linearity was reasonable 
since the points were roughly symmetrical in distribution around the diagonal line 
(Figure 35).  
The Durbin-Watson statistic was used to determine independence of errors, d = 
1.86, which was between 1.5 and 2.5 (Hutcheson & Sofroniou, 1999) and therefore the 
null hypothesis was not rejected and it could be concluded that the errors were not 
autocorrelated (Montgomery, Peck & Vining, 2012) and the assumption of 
independent errors was been met. 
Simple linear regression model. The results of the simple linear regression 
suggest that there was no significant relationship between the postoperative day two 
total oral morphine equivalent dose and BMI, F (1, 519) = 1.93, p = .275. BMI did not 
significantly account in the variability of the postoperative day two dose. This 
relationship remained insignificant after removal of the fifty-five influential cases with 
high leverage and one case with Mahalanobis D
2
 value p < .001, F (1, 465) = 3.03, p = 
.082. 
Hierarchical multiple regression. Hierarchical multiple regression was 
performed to investigate the relationship total postoperative day two oral morphine 
equivalent dose and BMI, after controlling for other factors related to stigma, such as 
age, gender, race, insurance status, and presence of psychiatric diagnoses, and also 
controlling for level of pain. Table 28 contains descriptive statistics for variables used. 
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Hierarchical regression assumptions described with outliers intact. 
Preliminary analyses were conducted to ensure no violations of the assumptions of 
normality of variances, linearity, and homoscedasticity. The assumption of normality 
of residuals was reasonable based on a normally distributed histogram (Figure 36) and 
linear P-P plot (Figure 37). Evidence of linearity was provided by scatterplots of 
standardized residuals versus predicted values that demonstrated a random distribution 
of points that displayed a roughly constant variance around the horizontal line for the 
total model (Figure 38) and each of the continuous independent variables, age and 
BMI, in partial regression plots (Figures 39 and 40). 
Examination of the correlation matrix (Table 29) and the variable inflation 
factor (VIF) values for the independent variables suggested that multicollinearity was 
not an issue (Montgomery, Peck & Vining, 2012). There was little to low correlation 
between all of the independent variables. VIF values were all less than 10 (1.019 – 
1.401) Most Eigenvalues were well above zero; however the values for moderate pain 
and BMI were close to zero (.039 and .002). The Condition Index for moderate pain 
was 10.66 suggesting a weak to moderate degree a multicollinearity and the value for 
the log transformed BMI was above 30 (44.194) suggesting a high degree (Callaghan 
& Chen, 2008), but multicollinearity was not assumed since only one independent 
variable had large variance proportions corresponding to the large moderate pain and 
BMI condition indices.  
The bivariate and partial correlations showed no significant relations among 
the continuous independent variables to total oral morphine equivalent dose and are 
shown in Table 30.  
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Hierarchical regression model with outliers intact. In the first step of 
hierarchical multiple regression, twelve predictors were entered: age, gender, race 
(black, Asian, all other), insurance status (Medicare, Medicaid, Worker’s 
Compensation, no insurance), presence of psychiatric diagnosis, and level of pain 
(mild pain, moderate pain). There were no cases of patients reporting moderate to 
moderate/severe pain, therefore these variables were not entered into the regression 
equation. The prediction model for the morphine equivalent dose during postoperative 
day two was significant, F (12, 498) = 2.32, p = .007, and accounted for 
approximately 5.3% of the variance of the equivalent dose (R
2
 = .053, Adjusted R
2
 = 
.030). After entry of the natural log transformed BMI at step 2 the total variance 
explained by the model as a whole remained 5.3% (R
2
 = .053, Adjusted R
2
 = .029), F 
(13, 497) = 2.16, p = .01. The introduction of BMI did not add significantly to the 
model. The addition explained an additional .1% of the variance in total dose, after 
controlling for age, gender, race (black, Asian, all other), insurance status (Medicare, 
Medicaid, Worker’s Compensation, no insurance), presence of psychiatric diagnosis, 
and level of pain (mild pain, moderate pain), R
2 
Change
  
= .001, F (1, 497) = .263, p = 
.608. The regression coefficients are listed Table 31 and show that BMI was a not a 
significant predictor in the model when controlling for the other variables. In the final 
model two out of thirteen predictor variables were statistically significant. Gender was 
a statistically significant predictor variable, β = -.219, p = .009, and being female 
would result in a 21.9% decrease in pain medication administration, 95% CI [-.384, -
.054], keeping all other variables constant. Worker’s Compensation patients received 
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83.4% more pain medication, 95% CIs [.553, 1.283] when keeping all other variables 
constant. 
Hierarchical regression assumptions described with outliers removed. 
Preliminary analyses were conducted to ensure no violations of the assumptions of 
normality of variances, linearity, and homoscedasticity. The assumption of normality 
of residuals was reasonable based on a normally distributed histogram (Figure 41) and 
linear P-P plot (Figure 42). Evidence of linearity was provided by scatterplots of 
standardized residuals versus predicted values that demonstrated a random distribution 
of points and a roughly constant variance around the horizontal line for the total model 
(Figure 43) and each of the continuous independent variables, age and BMI, in partial 
regression plots (Figures 44 and 45). 
Examination of the correlation matrix (Table 32) and the VIF values for the 
independent variables suggested that multicollinearity was not an issue (Montgomery, 
Peck & Vining, 2012). There was little to low correlation between the independent 
variables and VIF values were all less than 10 (1.012 – 1.404) Most Eigenvalues were 
well above zero; however the values for moderate pain and BMI were close to zero 
(.038 and .002). The Condition Index for moderate pain was 11.2 suggesting a weak to 
moderate degree a multicollinearity and the value for the log transformed BMI was 
above 30 (50.22) suggesting a high degree (Callaghan & Chen, 2008). No evidence of 
multicollinearity was assumed since only one independent variable had large variance 
proportions corresponding to each large condition indices.  
The bivariate and partial correlations showed small but significant relations to 
total oral morphine equivalent dose and are shown in Table 33. As can be seen, gender 
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was negatively and significantly correlated, indicating that when the gender was 
female, the amount of pain medication on postoperative day one decreased. There was 
a positive and significant correlation between the dose of pain medication and 
Worker’s Compensation. Patients with Worker’s Compensation tended to receive a 
higher dose of pain medication. BMI was not significantly correlated with the dose of 
pain medication. 
Hierarchical regression model with outliers removed. In the first step of 
hierarchical multiple regression, twelve predictors were entered: age, gender, race 
(black, Asian, all other), insurance status (Medicare, Medicaid, Worker’s 
Compensation, no insurance), presence of psychiatric diagnosis, and level of pain 
(mild pain, moderate pain). There were no cases of patients reporting moderate to 
moderate/severe pain, therefore these variables were not entered into the regression 
equation. The prediction model for the morphine equivalent dose during postoperative 
day two was significant, F (12, 444) = 1.66, p = .075, and accounted for 
approximately 4.3% of the variance of the equivalent dose (R
2
 = .043, Adjusted R
2
 = 
.017). After entry of the natural log transformed BMI at step 2 the model remained 
significant, F (13, 443) = 1.65, p = .068, and the total variance explained by the model 
as a whole 4.6% (R
2
 = .046, Adjusted R
2
 = .018). The introduction of BMI did not add 
significantly to the model. The addition explained an additional .4% of the variance in 
total dose, after controlling for age, gender, race (black, Asian, all other), insurance 
status (Medicare, Medicaid, Worker’s Compensation, no insurance), presence of 
psychiatric diagnosis, and level of pain (mild pain, moderate pain), R
2 
Change
  
= .004, 
F (1, 443) = 1.71, p = .192. The regression coefficients are listed Table 34 and show 
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that BMI was not a significant predictor in the model when controlling for the other 
variables. In the final model two out of thirteen predictor variables were statistically 
significant. Gender was a statistically significant predictor variable, β = -.190, p = 
.025, and being female would result in a 19% decrease in pain medication 
administration, 95% CI [-.356, -.024], keeping all other variables constant. Worker’s 
Compensation patients received 73.8% more pain medication, 95% CIs [.074, 1.402] 
when keeping all other variables constant.
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CHAPTER 5 
 
DISCUSSION AND CONCLUSIONS 
 
Obesity is a stigmatized condition and since other stigmatized groups have 
been shown to receive less pain medication it was hypothesized that obese individuals 
would receive less pain medication postoperatively than lower BMI groups. This study 
set out to explore ordering and administration practices of pain medication between 
normal, overweight, obesity class I, obesity class II, and obesity class II groups and 
has identified differences and relationships between groups. The literature on patient 
outcomes related to pain and obesity stigma is non-existent. The intention of this study 
was to begin exploration into obesity as a stigmatized condition that affects pain 
management and answer three questions: 
1. What is the difference in the total morphine equivalent dose of post-
surgical pain medication administered between normal weight, overweight, 
and obese (Class I, II, and III) adult non-bariatric surgery patients? 
2. What is the relationship between pain medication ordered and administered 
and the BMI of adult non-bariatric surgery patients? 
3. What is the relationship between patients’ BMI the receipt of post-surgical 
pain medication, when accounting for race, gender, age, insurance status, 
presence of psychiatric diagnosis, and pain score during hospitalization.  
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Independent Variables 
 There were differences in age (Tables 9 and 10), gender (Tables 11 and 12), 
insurance status (Table 13), and pain score (Tables 14 and 15). The differences in age, 
with the mean age decreasing as BMI increased, was most likely due to the heaviest 
patients dying earlier than the lighter patients since there numerous diseases associated 
with an increased weight (e.g., heart disease, cancer, etc) (Peeters et al., 2003). 
Another explanation for the decreasing age could have been due to the heavier patients 
needing to be hospitalized and needing surgery at an earlier age due to the presence of 
obesity-related diseases. Women are more susceptible to becoming obese and there are 
approximate three obese women for every two obese men (Wells, Marphatia, Cole & 
McCoy, 2012) and the higher proportion of obese females supports this. A greater 
proportion of private insurance in the overweight and obese groups compared to the 
normal BMI group may be explained by the sampling and types of surgeries 
performed. The sample included patients who were admitted on the same day as their 
surgeries and a vast majority of these surgeries are planned and scheduled ahead of 
time through the surgeons’ offices. Patients who schedule elective surgeries may be 
more likely to have private insurance. Also, another explanation could have been that 
the heavier patients were also younger and therefore may still have been employed and 
receiving private insurance through their employer. The findings related to pain scores 
were important since it showed that the obese III group was not complaining of 
moderate pain more or less than the normal, obesity class I, and obesity class II groups 
and there were no differences in mild pain between all groups. This variable may not 
have added much understanding of stigma since there were no moderate/severe or 
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severe pain scores recorded. In 2013, the healthcare system had multiple locations for 
which pain score may have been documented, including a paper record. One 
explanation for the low percentage of pain scores recorded in the medication 
administration system may have been that they were documented on paper. Also, it is 
possible that the pain scores recorded in the medication administration system could 
have been pain scores recorded after the administration of medication. They may have 
only been reflecting the improvement of pain, but it was not possible to determine this 
from the data set. 
Research Question One  
While there was a general downward trend of the mean dose of pain 
medication, the overweight, obesity class I, II, and III groups did not receive 
significantly less than the normal BMI group. It cannot be inferred that patients with 
high BMI received less pain medication (i.e., are stigmatized) than normal BMI 
patients. Taking into consideration the 37.3% of adults in Rhode Island (28.3% 
nationally) who are overweight and the 27.3% (28.3% nationally) who are obese, 
higher weights are becoming the norm. (Centers for Disease Control and Prevention, 
2015). Studies have described a tendency to perceive higher weights as normal 
(Tschamler, Conn, Cook & Halterman, 2009, De La O et al., 2009, Johnson, Cooke, 
Croker & Wardle, 2008). In a study examining perceived discrimination, Carr & 
Friedmnan (2005) found no difference between normal and overweight groups. In 
addition to using a normal BMI population as a comparison group, comparing 
overweight patients to the heaviest patients may also be appropriate. Examining the 
results from this perspective, there was a significant difference in the dose of pain 
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medication given on postoperative day one between the overweight and obesity class 
III groups. The overweight group received more pain medication than the obesity class 
I and II groups and significantly more than the obesity class III group. Since the 
heaviest patients received less pain medication, stigmatization associated with patient 
weight may be present. This receipt of less pain medication by the heaviest groups 
may be as a result to negative attitudes from the healthcare providers. This would fit 
with Lewis & Van Puymbroeck’s (2008) description of discriminatory acts tied to 
negative attitudes. 
Research Question Two 
Comparing overall pain medication ordering and administration practices 
among the five BMI categories was inconclusive in demonstrating clear patterns and 
differences in proportion between groups. A greater proportion of acetaminophen was 
ordered and not administered to obesity class III patients than normal and overweight 
BMI patients, which does support the literature related to less pain medication 
administration for stigmatized groups, although this may not be a significant finding 
since acetaminophen is usually not the primary choice for postoperative pain 
medication. Another interesting finding was that there were a proportion of patients 
that were administered hydromorphone, morphine, fentanyl, meperidine, oxycodone, 
and acetaminophen without the medication having been ordered by a licensed 
independent practitioner. It is possible that these drugs may have been administered to 
patients as a result of a verbal order that never was entered into the electronic medical 
record. Finding an overall relationship among all medications that supported bias 
towards higher weight patients was difficult. This may have been due to other factors, 
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such as most pain medications are ordered on an “as needed” basis and clinicians have 
different interpretations of the intent of these orders (Gordon et al., 2008). Also, the 
“habitus” may have differed between postoperative units (Lauzon Clabo, 2008). For 
example, some units may treat pain while taking into consideration the individual 
needs of the patient, while other units may have treated pain more from the standpoint 
of pain associated with a particular type of surgical procedure and not weighted the 
patient’s experience as heavily. In future research this question needs to be approached 
differently, taking dose into consideration. Other factors besides stigma may also need 
to be accounted for when examining ordering and administration practices, such as 
level of knowledge regarding pain management or opioid safety and addiction. Also, 
since most patients have postoperative medications ordered, it may be more 
illuminating to examine the physician ordering practices in relation to recommended 
guidelines. Physician attitudes toward obese patients have been shown to affect 
prescribing patterns (Huizinga, 2012). Further study is needed to determine if ordering 
of pain medication is affected by weight. 
Research Question Three 
There was a significant relationship found between the total postoperative oral 
morphine equivalent dose administered on postoperative day one and BMI, while 
controlling for other variables related to other stigmatizing conditions. BMI was the 
highest weighted predictor. It has been described that obese patients do not need any 
more pain medication that normal BMI patients (Patanwala, Holmes & Erstad, 2014), 
but this study found that there was a decrease in pain medication dose as BMI 
increased. Age was not as weighted a predictor of receiving less pain medication as 
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being black or being female, although it could be considered comparable to these 
when accounting for the scale. For example, the gender and racial category could only 
increase by a unit of one, since the variables were measured as either being black or 
not and being male or being female. There was a larger range of possible increases 
with age. Worker’s Compensation patients and patients with a psychiatric diagnosis 
received a much greater proportion of pain medication dose, 90.8% and 23.2% more 
respectively. This finding may have been due to the characteristics of each group, such 
as being more demanding for pain medication or having surgical procedures that may 
be inherently more painful, but it may have also been due to the low amount of cases 
within the groups. There were only 19 Worker’s Compensation patients and 149 
patients with a psychiatric diagnosis in the sample. The findings of this study support 
the hypothesis that BMI is related to the treatment of pain and that increased weight, 
i.e. obesity, contributed to a lesser dose of pain medication administered. Past studies 
have linked stigma of race, gender, and age to pain medication administration 
practices that resulted in the receipt of less pain medication. While there was a low 
percent of the variance in total morphine equivalent dose explained by regression 
model (.6%) and a very low correlation between independent and dependent variables, 
this was understandable when taking into account the many factors in healthcare and 
human behavior which may impact the dose of medication received by the patient. 
BMI and the other independent variables were only a small portion of what may 
account for the dose of pain medication. The purpose of this study was to understand 
the relationship between the variables and small but significant relationships were 
found. These findings are supported by past research and there was persuasive initial 
 74 
 
evidence that obesity, also a stigmatized attribute, may have impacted the 
administration of medications for pain when taking into account other factors related 
to stigmatization.  
Limitations 
There were several limitations that affected this study. After removal of 
duplicate cases and cases with missing information, the obesity class II and III groups 
contained fewer cases than the other groups, 291 and 318 respectively, and therefore 
those groups did not achieve the needed cases to yield a power of .95 and the 
possibility of incorrectly rejecting the null hypothesis is higher. Also, the number of 
patients receiving pain medication on postoperative day two was less than on day one. 
There were only 525 patients for which pain medication was documented on 
postoperative day two. If interested in determining if any differences total dose of pain 
medication continued past postoperative day one then ensuring that there are more 
patients who received pain medication on day two are included in the sample would 
increase the probability of finding a significant result. 
Another limitation was that data was not collected through a random sample, 
but through IS query based on criteria. Sampling from three different hospitals did 
strengthen the generalizability of this study; however non-random sampling decreases 
the ability of the results to be generalized to a larger or different population. While 
differences in independent variables could be explained from the literature, some of 
these differences may have introduced sampling bias since the sample was not equally 
balanced. Also there was an unequal sample size among the five categories. The 
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obesity class II and III groups had fewer cases than the other groups due to exclusion 
and removal. 
The use of BMI was another limitation. BMI is a measure of weight status that 
depends upon a patient’s height and weight to determine a value that places them 
within a category that can be used to flag the patient as being under weight, normal 
weight, overweight, or obese. A patient may have a very low percentage of body fat, 
but be considered obese by measurement if they have a large muscle mass combined 
with a shorter stature. Some patients falling into this category may be present in the 
sample, but it was impossible to determine this based on the data acquired. 
Another limitation was that pain score was recorded in the electronic medical 
record for only 48% of the cases. This may have been due to the multiple locations 
that nurses document pain, including both paper and electronic records. Also, the pain 
scores that were recorded in the medication administration system were categorical, 
grouping pain scores into categories, and not continuous. This would not precisely 
capture pain scores reported by each patient. There was not an adequate representation 
of each patient’s pain as there would be if an integrated electronic medical record 
existed. 
Finally, the categorization of race within the electronic medical record was 
suspect. There were a large proportion of patients classified as “White” within the 
study. Many of these patients had languages other than English listed as a primary 
language. “White” therefore was not an accurate representation of race since it 
appeared that Hispanic, as well as other race designations, were most likely included 
in the variable category. 
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Symbolic Interaction  
The actions that healthcare providers take toward their patients are based on 
the meaning that they attribute to them or their conditions. If there is a negative 
meaning attributed, then care of the patient may be adversely affected. This was 
described in past studies examined the impact of racial bias on pain medication 
administration. This study supports the premise that meaning is reflected in action 
since there was a difference in the amount of pain medication a patient received based 
on their BMI. As BMI increased, the amount of pain medication administered 
decreased. Stigma related to obesity may have been a factor. Since a difference was 
found, further research that incorporates measures of attitude or bias is important in 
determining the presence and extent of obesity stigma, and the meanings that are held 
by healthcare providers. The third premise of symbolic interaction, that meanings are 
assigned and modified through an interpretive process, will be important in developing 
interventional studies designed to modify meanings that are attached to obesity. The 
decision to use symbolic interaction, and not critical theory or critical interactionism, 
as a framework to guide meaning and assumptions was based on the micro-level view 
of the research. Pain medication administration was viewed at the individual 
perspective. The assumption that nurses derive meaning from obesity which creates 
stigma and negatively affects healthcare outcomes, i.e. pain medication administration, 
was central in this study. Pain medication administration had never been examined in 
relation to obesity stigma; therefore it was important to first understand if there were 
any differences in administration based on BMI. Future research could incorporate 
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critical social theory, using a critical interactionist perspective to address the 
individual/micro level as well as the organizational/societal/macro level. 
Implications for Research  
The findings of this study did show that there was a difference in the receipt of 
pain medication depending on BMI, and that as BMI increased the dose of medication 
decreased. Only an implied association of these findings to stigmatization can be made 
and more research is needed to strengthen the evidence. Mixed-methods research that 
combines the measurement of outcomes with a tool to measure attitudes and biases 
would be valuable in strengthening the theory that obesity stigma negatively affects 
the treatment of pain. Also, expanding the study to include different patient or 
healthcare facility types would increase the generalizability of any findings. 
Incorporation of qualitative research examining the meaning of obesity and its effect 
on pain control would contribute to the usefulness of symbolic interaction as an 
explanatory theory regarding the under treatment of pain in obese patients. Further 
research using the theory would be useful in developing interventional studies. Studies 
that use “priming” as an intervention may be effective in reducing stigma/stereotyping 
that impacts patient care (Burgess, van Ryn, Crowley-Matoka & Malat, 2006). 
“Priming” can be described as providing the subject(s) of interest with information 
that generates a specific attitude desirable by the researcher.  
Implications for Education 
Prior research involving students has described the presence of weight bias. 
Biases may continue on into clinical practice, maintaining an environment where 
stigma is perpetuated.  Educational interventions aimed at students would improve 
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attitudes, decrease bias, and ultimately may improve pain management in obese 
patients. It would be important to incorporate education designed to decrease obesity 
stigma into nursing curriculum. Continuing education for clinicians may also decrease 
obesity stigmatization. Bariatric sensitivity training has been used successfully in 
decreasing weight bias in nurses (Falker & Sledge, 2001) and may have a positive 
impact on the treatment of pain. 
Implications for Practice 
Negative attitudes and bias toward obese patients have been described as often 
being implicit among healthcare providers. They are unaware of the impact of 
negative beliefs on decision making and care provided. Other studies have described 
individuals as being less likely to have negative attitudes toward obesity if education 
was provided on the uncontrollable causes of obesity (DeJong, 1980). Interventions 
designed to change attitudes may also have a positive impact on pain management. 
This study begins to shed light on the effect of BMI on nurses’ attitudes and behaviors 
related to the treatment of pain. Reducing bias would improve the quality of care. Pain 
management is of crucial importance to clinicians, especially due to quality of care 
and interest by government and accrediting agencies. Aspects of pain management are 
often included by hospitals as quality improvement measures. The Centers for 
Medicare and Medicaid Services include pain as an indicator in its Hospital Consumer 
Assessment of Healthcare Providers and Systems survey (CMS.gov, 2014). Pain 
management is also a concern of The Joint Commission (The Joint Commission, 
2015). The results of this study indicate that there are differences in the treatment of 
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pain based on BMI, which if improved would also improve survey results and the 
quality indicators. 
Healthcare, caring for our patients, and providing care are examples of 
terms/phrases that healthcare providers use when describing what they do as a 
profession. Caring and stigma should be considered mutually exclusive concepts. The 
meaning providers attach to being obese affects their thought and actions. By allowing 
stigma, either consciously or unconsciously, to have an impact on care we are setting 
up situations of inequality. All patients deserve to receive the very best quality of care 
regardless of weight. 
 
 “Our prime purpose in this life is to help others. And if you can’t help them, at 
least don’t hurt them.” Dalai Lama. 
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Table 2. 
Post-operative pain medications  
Medication Classification Indication  Dosage Frequency
Morphine Therapeutic: 
opioid analgesics
Severe pain Intramuscular, Intravenous, Subcutaneous 
(Adults ≥50 kg): 
Usual starting dose for moderate to severe pain 
in opioid-naive patients—4–10 mg every 3–4 
hours. 
For very severe pain additional smaller doses 
may be given every 3–4 hours.
Hydromorphone Therapeutic: 
opioid analgesics
Moderate to severe pain (alone 
and in combination with 
nonopioid analgesics)
Intravenous, Intramuscular, Subcutaneous 
(Adults ≥50 kg): 
1.5 mg q 3–4 hr as needed initially; may be ↑.
Hydrocodone Therapeutic: 
opioid analgesics
Used mainly in combination 
with nonopioid analgesics 
(acetaminophen/ibuprofen) in 
the management of moderate to 
severe pain.
Oral (Adults): 
Analgesic—2.5–10 mg q 3–6 hr as needed; if 
using combination products, acetaminophen 
dosage should not exceed 4 g/day and should 
not exceed 5 tablets/day of ibuprofen-
containing products
Fentanyl Citrate Therapeutic: 
opioid analgesics
Preoperative and postoperative analgesia.I tramuscular, Intravenous (Adults and 
Children > 12 yr): 
50–100 mcg; may repeat in 1–2 hr.
Meperidine Therapeutic: 
opioid analgesics
Moderate or severe pain (alone 
or with nonopioid agents).
Oral, Intramuscular, Subcutaneous (Adults): 
Analgesia—50 mg q 3-4 hr; may be ↑ as 
needed (not to exceed 600 mg/24 hr).
Oxycodone Therapeutic: 
opioid analgesics
Moderate to severe pain Oral (Adults ≥50 kg): 5–10 mg q 3–4 hr 
initially, as needed.
Acetaminophen Therapeutic: 
antipyretics, non-
opioid analgesics 
Oral, Rectal: Treatment of: 
Mild pain.
Intravenous: Treatment of: Mild 
to moderate pain, Moderate to 
severe pain with opioid 
analgesics.
Oral (Adults and Children >12 yr): 325–650 
mg q 4–6 hr or 1 g 3–4 times daily or 1300 mg 
q 8 hr (not to exceed 4 g or 2.5 g/24 hr in 
patients with hepatic/renal impairment). 
Intravenous (Adults and Children ≥13 yr and 
≥50 kg): 1000 mg q 6 hr or 650 mg q 4 hr (not 
to exceed 4 g/day or less than 4 hr dosing 
interval).
 
Source: Nursing Reference Center, (2015). 
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Table 2. 
Post-operative pain medications (cont’d). 
Medication Classification Indication  Dosage Frequency
Ibuprophen Therapeutic: 
antipyretics, 
antirheumatics, 
non-opioid 
analgesics, 
nonsteroidal anti-
inflammatory 
agents 
Oral, Intravenous: Treatment 
of: Mild to moderate pain, 
Fever. Oral: Treatment of: 
Inflammatory disorders 
including rheumatoid arthritis 
(including juvenile) and 
osteoarthritis, Dysmenorrhea. 
Intravenous: Moderate to 
severe pain with opioid 
analgesics. 
Oral (Adults): Anti-inflammatory—400–800 
mg 3–4 times daily (not to exceed 3200 
mg/day). 
Analgesic/antidysmenorrheal/antipyretic—200–
400 mg q 4–6 hr (not to exceed 1200 
mg/day). 
Intravenous (Adults): Analgesic—400–800 mg 
q 6 hr as needed (not to exceed 3200 mg/day); 
Antipyretic—400 mg initially, then 400 mg q 
4–6 hr or 100–200 mg q 4 hr as needed (not 
to exceed 3200 mg/day). 
Ketorolac Therapeutic: 
nonsteroidal anti-
inflammatory 
agents, non-
opioid analgesics 
Short-term management of pain 
(not to exceed 5 days total for 
all routes combined). 
Intravenous (Adults <65 yr): Single dose—30 
mg. Multiple dosing—30 mg q 6 hr (not to 
exceed 120 mg/day). 
Intravenous (Adults ≥65 yr, <50 kg, or with 
renal impairment): Single dose—15 mg. 
Multiple dosing—15 mg q 6 hr (not to exceed 
60 mg/day).
Diclofenac Therapeutic: non-
opioid analgesics, 
nonsteroidal anti-
inflammatory 
agents
Oral: Management of 
inflammatory disorders 
including: Rheumatoid arthritis, 
Osteoarthritis, Ankylosing 
spondylitis. Primary 
dysmenorrhea. Relief of mild to 
moderate pain. Acute treatment 
of migraines (powder for oral 
solution). 
Oral (Adults): Rheumatoid arthritis (delayed-
release [enteric-coated] tablets)—50 mg 3–4 
times daily or 75 mg twice daily (usual 
maintenance dose 25 mg 3 times daily). 
Rheumatoid arthritis (extended-release 
tablets)—100 mg once daily; if unsatisfactory 
response, dose may be ↑ to 100 mg twice 
daily. Osteoarthritis (delayed-release [enteric-
coated] tablets)—50 mg 2–3 times daily or 75 
mg twice daily. Osteoarthritis (extended-
release tablets)—100 mg once daily. 
Ankylosing spondylitis (delayed-release 
[enteric-coated] tablets)—25 mg 4 times daily, 
with an additional 25 mg given at bedtime, if 
necessary.
 
Source: Nursing Reference Center, (2015). 
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Table 3. 
Narcotics and their Narcotic Equivalency to Oral Morphine 
 
 
Equianalgesia (morphine, PO)
Analgesic Strength Equivalent Dose
(relative) (10 mg)
Morphine (IV/IM) 3 3.33 mg
Codeine 1⁄10 100 mg
Meperidine 1⁄3 28 mg
Hydrocodone 1 10 mg
Oxycodone 1.5 6.67 mg
Hydromorphone 5 2 mg
Fentanyl 50–100 0.1–0.2 mg
Ketorolac 30 10 mg
 
Source: GlobalRPh (2015). 
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
LAPAROSCOPIC GASTROENTEROSTOMY 106
FUSION OR REFUSION OF 2-3 VERTEBRAE 100
RADICAL PROSTATECTOMY 89
LAPAROSCOPIC CHOLECYSTECTOMY 81
OTHER LYSIS OF PERITONEAL ADHESIONS 71
REGIONAL LYMPH NODE EXCISION 70
IV DISC EXCISION 68
OTHER PARTIAL RESECTION OF SMALL INTESTINE 65
PROCEDURE ON SINGLE VESSEL 60
EXCISION OF OTHER BONE FOR GRAFT, EXCEPT FACIAL BONES 59
LUMBAR AND LUMBOSACRAL FUSION OF THE POSTERIOR COLUMN, POSTERIOR 55
NEPHROURETERECTOMY 53
LAPAROSCOPIC LYSIS OF PERITONEAL ADHESIONS 52
LAPAROSCOPIC APPENDECTOMY 51
LAPAROSCOPIC RIGHT HEMICOLECTOMY 49
ENDARTERECTOMY OF OTHER VESSELS OF HEAD AND NECK 47
OTHER OPEN INCISIONAL HERNIA REPAIR WITH GRAFT OR PROSTHESIS 47
INSERTION OF INTERBODY SPINAL FUSION DEVICE 45
SIMPLE EXCISION OF OTHER LYMPHATIC STRUCTURE 44
OTHER CERVICAL FUSION OF THE ANTERIOR COLUMN, ANTERIOR TECHNIQUE 41
PARTIAL NEPHRECTOMY 41
OTHER EXPLORATION AND DECOMPRESSION OF SPINAL CANAL 40
CLOSURE OF STOMA OF SMALL INTESTINE 38
LAPAROSCOPIC REPAIR OF DIAPHRAGMATIC HERNIA, ABDOMINAL APPROACH 37
LAPAROSCOPIC SIGMOIDECTOMY 35
THORACOSCOPIC EXCISION OF LESION OR TISSUE OF LUNG 33
FIBER-OPTIC BRONCHOSCOPY 32
OTHER OPERATIONS ON BONE MARROW 32
THORACOSCOPIC LOBECTOMY OF LUNG 30
INTRAOPERATIVE CHOLANGIOGRAM 28
EXTERIORIZATION OF SMALL INTESTINE 27
LAPAROSCOPIC PROCEDURES FOR CREATION OF ESOPHAGOGASTRIC SPHINCTERIC 27
OTHER INCISION WITH DRAINAGE OF SKIN AND SUBCUTANEOUS TISSUE 27
COMPLETE THYROIDECTOMY 26
INSERTION OF INTERCOSTAL CATHETER FOR DRAINAGE 26
OTHER RESECTION OF RECTUM 26
OTHER ANTERIOR RESECTION OF RECTUM 25
ENDARTERECTOMY OF LOWER LIMB ARTERIES 23  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
OTHER (PERIPHERAL) VASCULAR SHUNT OR BYPASS 23
OTHER BRONCHOSCOPY 23
PERCUT NEPHROST-NO FRAG 23
PROCEDURE ON TWO VESSELS 23
RETROGRADE PYELOGRAM 23
ANGIOPLASTY OF OTHER NON-CORONARY VESSEL(S) 22
OTHER LOBECTOMY OF LUNG 22
BIOPSY OF LYMPHATIC STRUCTURE 21
LAPAROSCOPIC VERTICAL (SLEEVE) GASTRECTOMY 21
LARGE-TO-LARGE INTESTINAL ANASTOMOSIS 21
ARTERIOGRAPHY OF FEMORAL AND OTHER LOWER EXTREMITY ARTERIES 20
FORMATION OF CUTANEOUS URETERO-ILEOSTOMY 20
CLOSURE OF STOMA OF LARGE INTESTINE 19
OTHER LAPAROSCOPIC UMBILICAL HERNIORRHAPHY 19
RADICAL CYSTECTOMY 19
OTHER ENDOSCOPY OF SMALL INTESTINE 18
PROCEDURE ON VESSEL BIFURCATION 18
EXCISION OF LESION OF OTHER SOFT TISSUE 17
LAPAROSCOPIC LYSIS OF PIRIRENAL OR PERIURETERAL ADHESIONS 17
OPEN AND OTHER SIGMOIDECTOMY 17
PERCUTANEOUS ABDOMINAL DRAINAGE 17
TOTAL KNEE REPLACEMENT 17
UNILATERAL THYROID LOBECTOMY 17
EXCISION OR DESTRUCTION OF PERITONEAL TISSUE 16
LAPAROSCOPY 16
OPEN AND OTHER RIGHT HEMICOLECTOMY 16
OTHER SMALL-TO-LARGE INTESTINAL ANASTOMOSIS 16
CHOLECYSTECTOMY 15
ENDOVASCULAR IMPLANTATION OF OTHER GRAPH IN ABDOMINAL AORTA 14
OTHER OPEN UMBILICAL HERNIORRHAPHY 14
SINGLE INTERNAL MAMMARY-CORONARY ARTERY BYPASS 14
TRANSURETHRAL REMOVAL OF OBSTRUCTION FROM URETER 14
OTHER AND OPEN REPAIR OF OTHER HERNIA OF ANTERIOR ABDOMINAL WALL WITH 13
OTHER CYSTOSCOPY 13
OTHER LOCAL EXCISION OR DESTRUCTION OF LESION OR TISSUE OF 13
OTHER LYSIS OF PERIRENAL OR PERIURETERAL ADHESIONS 13
OPEN AND OTHER LEFT HEMICOLECTOMY 12
OPEN AND OTHER REPLACEMENT OF AORTIC VALVE WITH TISSUE GRAFT 12
OTHER INCISION OF PLEURA 12  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
REMOVAL OF INTERNAL FIXATION DEVICE FROM OTHER BONE, 12
UNILATERAL EXTENDED SIMPLE MASTECTOMY 12
ANASTOMOSIS OF SMALL INTESTINE TO ANUS 11
CLOSURE OF FISTULA OF SMALL INTESTINE, EXCEPT DUODENUM 11
COLOSTOMY, NOT OTHERWISE SPECIFIED 11
FUSION OR REFUSION OF 4-8 VERTEBRAE 11
INCISION OF ABDOMINAL WALL 11
INSERTION OF ENDOTRACHEAL TUBE 11
LAPAROSCOPIC REMOVAL OF GASTRIC RESTRICTIVE DEVICE(S) 11
LAPAROSCOPIC TOTAL INTRA-ABDOMINAL COLECTOMY 11
ESOPHAGOMYOTOMY 10
INSERTION OF BREAST TISSUE EXPANDER 10
INSERTION OF NON-DRUG-ELUTING PERIPHERAL (NON-CORONARY) VESSEL STENT(S) 10
LAPAROSCOPIC LEFT HEMICOLECTOMY 10
OTHER HERNIA REPAIR 10
OTHER TRANSURETHRAL PROSTATECTOMY 10
PERCUT NEPHROST W FRAGMN 10
PERCUTANEOUS PYELOGRAM 10
ARTERIOGRAPHY OF OTHER INTRA-ABDOMINAL ARTERIES 9
CLOSURE OF SKIN AND SUBCUTANEOUS TISSUE OTHER SITES 9
INCISIONAL HERNIA REPAIR 9
INSERTION OF OTHER (NASO-)GASTRIC TUBE 9
OTHER KIDNEY TRANSPLANTATION 9
OTHER PARATHYROIDECTOMY 9
OTHER PROCTOPEXY 9
RADICAL EXCISION OF OTHER LYMPH NODES 9
REPAIR OF OTHER HERNIA OF ANTERIOR ABDOMINAL WALL 9
TOTAL SPLENECTOMY 9
CORRECTION OF URETEROPELVIC JUNCTION 8
FLEXIBLE SIGMOIDOSCOPY 8
OTHER REPAIR AND PLASTIC OPERATIONS ON SPINAL CORD STRUCTURES 8
OTHER TRANSURETHRAL EXCISION OR DESTRUCTION OF 8
REVISION OF STOMA OF SMALL INTESTINE 8
(AORTO)CORONARY BYPASS OF ONE CORONARY ARTERY 7
(AORTO)CORONARY BYPASS OF TWO CORONARY ARTERY 7
AORTOGRAPHY 7
EXCISION OR DESTRUCTION OF LESION OR TISSUE OF ABDOMINAL 7
ILEOSTOMY, NOT OTHERWISE SPECIFIED 7
INJECTION INTO THORACIC CAVITY 7
INSERTION OF ONE VASCULAR STENT 7  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
LAPAROSCOPIC CECECTOMY 7
LUMBAR AND LUMBOSACRAL FUSION OF THE ANTERIOR COLUMN, POSTERIOR 7
NONEXCISIONAL DEBRIDEMENT OF WOUND, INFECTION, OR BURN 7
OTHER AND UNSPECIFIED PARTIAL EXCISION OF LARGE INTESTINE 7
OTHER ENDOVASCULAR PROCEDURES ON OTHER VESSELS 7
OTHER REPAIR OF ANAL SPHINCTER 7
RECONSTRUCTION OF URINARY BLADDER 7
REPAIR OF PERICOLOSTOMY HERNIA 7
THORACOSCOPIC SEGMENTAL RESECTION OF LUNG 7
UNILATERAL SIMPLE MASTECTOMY 7
AORTA-ILIAC-FEMORAL BYPASS 6
APPLICATION OR ADMINISTRATION OF AN ADHESION BARRIER SUBSTANCE 6
CLOSED BIOPSY OF LIVER 6
COLONOSCOPY 6
EXCISION OF AXILLARY LYMPH NODE 6
INTRAVENOUS PYELOGRAM 6
LAPAROSCOPIC INCISIONAL HERNIA REPAIR WITH GRAFT OR PROSTHESIS 6
OTHER EXCISION OF JOINT OF OTHER SPECIFIED SITE 6
OTHER EXCISION OR DESTRUCTION OF LESION OR TISSUE OF BRAIN 6
OTHER GASTROSTOMY 6
OTHER MAMMOPLASTY 6
OTHER PARTIAL THYROIDECTOMY 6
OTHER PERMANENT ILEOSTOMY 6
OTHER PROSTATECTOMY 6
OTHER REPAIR OF CEREBRAL MENINGES 6
PELVIC EVISCERATION 6
PROCEDURE ON THREE VESSELS 6
RETROPUBIC PROSTATECTOMY 6
SUTURE OF LACERATION OF SMALL INTESTINE, EXCEPT DUODENUM 6
TRANSPLANT FROM CADAVER 6
DILATION OF URETHRA 5
EXCISIONAL DEBRIDEMENT OF WOUND, INFECTION, OR BURN 5
EXPLORATORY LAPAROTOMY 5
LAPAROSCOPIC ABDOMINOPERINEAL RESECTION OF THE RECTUM 5
MEDIASTINOSCOPY 5
OPEN ABDOMINOPERINEAL RESECTION OF THE RECTUM 5
OTHER AND OPEN REPAIR OF UMBILICAL HERNIA WITH GRAFT OR PROSTHESIS 5
OTHER APPENDECTOMY 5
OTHER ENTEROSTOMY 5
OTHER GASTROENTEROSTOMY WITHOUT GASTRECTOMY 5  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
OTHER INCISION OF SMALL INTESTINE 5
OTHER LOCAL DESTRUCTION OR EXCISION OF RENAL LESION OR TISSUE 5
OTHER PROCEDURES FOR CREATION OF ESOPHAGOGASTRIC 5
OTHER SKIN GRAFT TO OTHER SITES 5
PARTIAL GASTRECTOMY WITH ANASTOMOSIS TO JEJUNUM 5
PARTIAL HEPATECTOMY 5
REOPENING OF RECENT LAPAROTOMY SITE 5
REPLACEMENT OF VENTRICULAR SHUNT 5
REVERSE TOTAL SHOULDER REPLACEMENT 5
SMALL-TO-SMALL INTESTINAL ANASTOMOSIS 5
THERAPEUTIC APHERESIS NEC 5
THORACENTESIS 5
ABD AORTA RESECT W REPL 4
ABDOMINAL PROCTOPEXY 4
ANTERIOR RESECTION OF RECTUM WITH SYNCHRONOUS COLOSTOMY 4
ARTERIOGRAPHY OF CEREBRAL ARTERIES 4
ATTACHMENT OF PEDICLE OR FLAP GRAFT TO OTHER SITES 4
BILATERAL SIMPLE MASTECTOMY 4
ELECTROMYOGRAPHY 4
ENDOVASCULAR IMPLANTATION OF BRANCHING OR FENESTRATED GRAFT(S) IN AORTA 4
EXCISION OF BONE FOR GRAFT, UNSPECIFIED SITE 4
EXCISION OR DESTRUCTION OF LESION OF CHEST WALL 4
EXCISION OR DESTRUCTION OF LESION OF SPINAL CORD 4
EXCISION OR DESTRUCTION OF LESION OR TISSUE OF MEDIASTINUM 4
INCISION OF LOWER LIMB ARTERIES 4
INCISION OF PERIRECTAL TISSUE 4
ISOLATION OF SEGMENT OF SMALL INTESTINE 4
LAPAROSCOPIC LIVER BIOPSY 4
LOCAL EXCISION OF OTHER LESION OR TISSUE OF STOMACH 4
MULTIPLE SEGMENTAL RESECTION OF SMALL INTESTINE 4
NEPHROTOMY 4
OTHER AMPUTATION BELOW KNEE 4
OTHER AND OPEN REPAIR OF INDIRECT INGUINAL HERNIA WITH GRAFT 4
OTHER AND UNSPECIFIED TOTAL ABDOMINAL HYSTERECTOMY 4
OTHER AND UNSPECIFIED TOTAL INTRA-ABDOMINAL COLECTOMY 4
OTHER CERVICAL FUSION OF THE POSTERIOR COLUMN, POSTERIOR TECHNIQUE 4
OTHER FASCIECTOMY 4
OTHER GENITOURINARY INSTILLATION 4
OTHER INCIDENTAL APPENDECTOMY 4
OTHER PULL-THROUGH RESECTION OF RECTUM 4  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
OTHER REPAIR OF ABDOMINAL WALL 4
OTHER REVISION OF VASCULAR PROCEDURE 4
OTHER SUTURE OF MUSCLE OR FASCIA 4
PARTIAL CYSTECTOMY 4
PARTIAL EXCISION OF PITUITARY GLAND, TRANSSPHENOIDAL APPROACH 4
PERITONEAL LAVAGE 4
REFUSION OF LUMBAR AND LUMBOSACRAL SPINE, POSTERIOR COLUMN, POSTERIOR 4
RESECTION OF OTHER THORACIC VESSELS WITH REPLACEMENT 4
RIGID PROCTOSIGMOIDOSCOPY 4
SUPRAPUBIC PROSTATECTOMY 4
THORACOSCOPIC DECORTICATION OF LUNG 4
ARTERIOGRAPHY OF OTHER SPECIFIED SITES 3
ARTHROCENTESIS 3
CLIPPING OF ANEURYSM 3
CLOSED BIOPSY OF BRONCHUS 3
CLOSED REDUCTION OF MANDIBULAR FRACTURE 3
CLOSURE OF ANAL FISTULA 3
CLOSURE OF OTHER GASTRIC FISTULA 3
COMPLETE SUBSTERNAL THYROIDECTOMY 3
CONTROL OF HEMORRHAGE, NOT OTHERWISE SPECIFIED 3
DECAPSULATION OF KIDNEY 3
DECOMPRESSION OF TRIGEMINAL NERVE ROOT 3
INCISION WITH REMOVAL OF FOREIGN BODY OR DEVICE FROM SKIN AND 3
INSERTION OF TWO VASCULAR STENTS 3
LAPAROSCOPIC INCIDENTAL APPENDECTOMY 3
LOCAL EXCISION OF RECTAL LESION OR TISSUE 3
OPEN AND OTHER REPLACEMENT OF AORTIC VALVE 3
OPEN HEART VALVULOPLASTY OF AORTIC VALVE WITHOUT REPLACEMENT 3
OPEN OSTEOPLASTY (OSTEOTOMY) OF MANDIBULAR RAMUS 3
OPEN TOTAL INTRA-ABDOMINAL COLECTOMY 3
OTHER AND OPEN REPAIR OF DIRECT INGUINAL HERNIA WITH GRAFT 3
OTHER AND UNSPECIFIED SEGMENTAL RESECTION OF LUNG 3
OTHER LAPAROTOMY 3
OTHER LOCAL EXCISION OR DESTRUCTION OF LESION OF KNEE JOINT 3
OTHER OPERATIONS ON LUNG 3
OTHER OPERATIONS ON THORAX 3
OTHER REPAIR OF ANEURYSM 3
OTHER REPAIR OF CHEST WALL 3
OTHER REPAIR OF PENIS 3
PARATHYROID TISSUE REIMPLANTATION 3  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
REMOVAL OF INTERNAL PROSTHESIS OF PENIS 3
REMOVAL OF PYELOSTOMY AND NEPHROSTOMY TUBE 3
REOPENING OF LAMINECTOMY SITE 3
REPAIR OF COLOVAGINAL FISTULA 3
REPAIR OF RECTOVAGINAL FISTULA 3
REPAIR OF VERTEBRAL FRACTURE 3
REVISION OF URETEROINTESTINAL ANASTOMOSIS 3
SIZE REDUCTION PLASTIC OPERATION 3
SUBTOTAL MASTECTOMY 3
SUTURE OF ARTERY 3
SUTURE OF DUODENAL ULCER SITE 3
THORACOSCOPIC DRAINAGE OF PLEURAL CAVITY 3
TOTAL HIP REPLACEMENT 3
TRANSPLEURAL THORACOSCOPY 3
ULTRASONIC FRAGMENTATION OF URINARY STONES 3
URETERONEOCYSTOSTOMY 3
URETEROSCOPY 3
VIDEO AND RADIO-TELEMETERED ELECTROENCEPHALOGRAPHIC MONITORING 3
AMPUTATION ABOVE KNEE 2
ANASTOMOSIS OF HEPATIC DUCT TO GASTROINTESTINAL TRACT 2
APPLICATION OF EXTERNAL FIXATOR DEVICE, TIBIA AND FIBULA 2
APPLICATION OF OTHER WOUND DRESSING 2
ASPIRATION OF OTHER SOFT TISSUE 2
BIOPSY OF ABDOMINAL WALL OR UMBILICUS 2
CLOSED BIOPSY OF BLADDER 2
COMPUTER ASSISTED SURGERY WITH CT/CTA 2
DEBRIDEMENT OF OPEN FRACTURE OF TIBIA AND FIBULA 2
DENTAL WIRING 2
DERMAL REGENERATIVE GRAFT 2
DISTAL PANCREATECTOMY 2
DORSAL AND DORSOLUMBAR FUSION OF THE ANTERIOR COLUMN, ANTERIOR TECHNIQUE 2
DORSAL AND DORSOLUMBAR FUSION OF THE POSTERIOR COLUMN, POSTERIOR 2
ENDARTERECTOMY OF ABDOMINAL ARTERIES 2
ENDOSCOPIC CONTROL OF GASTRIC OR DUODENAL BLEEDING 2
ENDOSCOPIC INSERTION OF STENT (TUBE) INTO BILE DUCT 2
ENDOVASCULAR (TOTAL) EMBOLIZATION OR OCCLUSION OF HEAD AND NECK VESSELS 2
ESOPHAGOGASTRODUODENOSCOPY (EGD) WITH CLOSED BIOPSY 2
EXCISION OF DEEP CERVICAL LYMPH NODE 2
EXCISION OF HEMORRHOIDS 2
EXCISION OF INGUINAL LYMPH NODE 2  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
EXCISION OF LESION OR TISSUE OF CEREBRAL MENINGES 2
EXCISION OF LESION OR TISSUE OF DIAPHRAGM 2
EXCISION OR DESTRUCTION OF OTHER LESION OR TISSUE OF HEART, OPEN 2
EXTRACRANIAL-INTRACRANIAL (EC-IC)VASCULAR BYPASS 2
FASCIOTOMY 2
FAT GRAFT OF SKIN AND SUBCUTANEOUS TISSUE 2
GASTROPEXY 2
IMPLANTATION OR REPLACEMENT OF PERIPHERAL NEUROSTIMULATOR LEAD(S) 2
INCISION OF ABDOMINAL VEINS 2
INCISION OF CEREBRAL MENINGES 2
INCISION OF PERIANAL ABSCESS 2
INCISION OF UPPER LIMB VESSELS 2
INSERTION OF CATHETER INTO SPINAL CANAL FOR INFUSION OF THERAPEUTIC 2
INSERTION OF RECOMBINANT BONE MORPHOGENETIC PROTEIN 2
INSERTION OR REPLACEMENT OF EXTERNAL VENTRICULAR DRAIN (EVD) 2
INTRA-ABDOMINAL MANIPULATION OF LARGE INTESTINE 2
LAPAROSCOPIC REMOVAL OF BOTH OVARIES AND TUBES AT SAME OPERATIVE EPISODE 2
LATISSIMUS DORSI MYOCUTANEOUS FLAP 2
LOBECTOMY OF LIVER 2
LOCAL EXCISION OF LESION OR TISSUE OF OTHER BONE, EXCEPT 2
NEPHROSCOPY 2
NEPHROSTOMY 2
OBLITERATION AND TOTAL EXCISION OF VAGINA 2
OPEN AND OTHER RESECTION OF TRANSVERSE COLON 2
OPEN BIOPSY OF BRAIN 2
OPEN REDUCTION OF MANDIBULAR FRACTURE 2
OTHER ABDOMINOPERINEAL RESECTION OF THE RECTUM 2
OTHER AND OPEN REPAIR OF DIRECT INGUINAL HERNIA 2
OTHER AND OPEN REPAIR OF INDIRECT INGUINAL HERNIA 2
OTHER AND UNSPECIFIED PNEUMONECTOMY 2
OTHER AND UNSPECIFIED ROBOTIC ASSISTED PROCEDURE 2
OTHER AND UNSPECIFIED SUBTOTAL ABDOMINAL HYSTERECTOMY 2
OTHER AND UNSPECIFIED THORACOSCOPIC OPERATIONS ON THYMUS 2
OTHER CRANIAL OSTEOPLASTY 2
OTHER CRANIOTOMY 2
OTHER ELECTRIC ERSHOCK OF HEART 2
OTHER IRRIGATION OF WOUND 2
OTHER LAPAROSCOPIC REPAIR OF OTHER HERNIA OF ANTERIOR ABDOMINAL WALL 2
OTHER MYECTOMY 2
OTHER PARTIAL PANCREATECTOMY 2  
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Table 4. 
Procedures performed on more than one patient. 
Procedure Count
OTHER PYLOROPLASTY 2
OTHER REPAIR OF BLADDER 2
OTHER REPAIR OF INTESTINE 2
OTHER REPAIR OF STOMACH 2
OTHER REVISION OF STOMA OF LARGE INTESTINE 2
OTHER SUPRAPUBIC CYSTOSTOMY 2
OTHER UNILATERAL FEMORAL HERNIORRHAPHY 2
OTHER UNILATERAL SALPINGO-OOPHORECTOMY 2
OTHER URETHROSCOPY 2
PEDICLE GRAFT TO BREAST 2
PERCUTANEOUS ASPIRATION OF KIDNEY (PELVIS) 2
PLICATION OF VENA CAVA 2
PULL-THROUGH RESECTION OF RECTUM, NOT OTHERWISE SPECIFIED 2
PULMONARY ARTERY WEDGE MONITORING 2
RADICAL GROIN DISSECTION 2
RADICAL NECK DISSECTION, UNILATERAL 2
REFUSION OF LUMBAR AND LUMBOSACRAL SPINE, ANTERIOR COLUMN, ANTERIOR 2
REMOVAL OF TRANSPLANTED OR REJECTED KIDNEY 2
REOPENING OF WOUND OF THYROID FIELD 2
REPAIR OF DIAPHRAGMATIC HERNIA WITH THORACIC APPROACH, 2
REPAIR OF DIAPHRAGMATIC HERNIA, ABDOMINAL APPROACH, NOT OTHERWISE 2
REPAIR OF FISTULA INVOLVING BLADDER AND INTESTINE 2
REPAIR OF RECTOCELE 2
REVISION OF AMPUTATION STUMP 2
REVISION RHINOPLASTY 2
SEGMENTAL OSTEOPLASTY (OSTEOTOMY) OF MAXILLA 2
SUTURE OF GASTRIC ULCER SITE 2
SUTURE OF LACERATION OF DIAPHRAGM 2
SUTURE OF LACERATION OF LIP 2
SUTURE OF LACERATION OF RECTUM 2
THORACOSCOPIC PLEURAL BIOPSY 2
TOTAL URETERECTOMY 2
TRANSPLANT FROM LIVE NON-RELATED DONOR 2
TRANSURETHRAL CLEARANCE OF BLADDER 2
UNILATERAL ADRENALECTOMY 2
UNILATERAL REPAIR OF INGUINAL HERNIA WITH GRAFT OR 2
URINARY DIVERSION TO INTESTINE 2
VAGINAL RECONSTRUCTION 2
VENTRICULAR SHUNT TO ABDOMINAL CAVITY AND ORGANS 2
(AORTO)CORONARY BYPASS OF THREE CORONARY ARTERIES 1  
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Table 6. 
Frequency of postoperative day one and two pain medications. 
Medications Postoperative Day 1 Postoperative Day 2
IV Narcotic Hydromorphone 1478 (86.7%) 310 (18.2%)
Morphine 478 (28.1%) 114 (6.7%)
Fentanyl 49 (2.9%) 17 (1%)
Meperidine 52 (3.1%) 4 (.2%)
PO Narcotic Oxycodone 92 (5.4% 144 (8.5%)
IM Non-Narcotic Ketorolac 131 (7.7% 151 (8.9%)
IV Non - Narcotic Acetaminophen 243 (14.3%) 69 (4%)
PO Non-Narcotic Ibuprophen 0 (0%) 2 (.1 %)  
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Table 7. 
Descriptive statistics for total dose in mg of each pain medication administered during 
postoperative day one and two. 
Medications
Mean Min Max Std Dev Mean Min Max Std Dev
Hydromorphone 2.44 0.25 203 5.53 2.19 0.25 105 6.75
Morphine 7.84 0.25 60 6.31 7.55 1 45 8.21
Fentanyl 170.37 0.25 700 171.65 187.67 2.5 850 212.45
Meperidine 29.33 12.5 225 30 90.63 12.5 225 93.19
Oxycodone 28.07 5 380 51.1 18 5 95 14.74
Ketorolac 28.4 1 90 13.33 27.65 15 105 14.2
Acetaminophen 1068.72 650 2000 269.53 1030.68 10 2000 261.45
Postoperative Day 1 Postoperative Day 2
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Table 8. 
Descriptive statistics of total postoperative day 1 and day 2 morphine equivalent dose. 
Total 24-Hour Morphine Equivalent Dose Total 48-Hour Morphine Equivalent Dose
N 352.0 115.0
Mean 20.9 16.4
Minimum 1.3 2.5
Maximum 232.5 157.5
Std. Deviation 23.6 20.6
% of Total N 21.6% 22.0%
N 346.0 95.0
Mean 18.8 24.4
Minimum 2.5 0.6
Maximum 117.3 525.0
Std. Deviation 12.1 56.4
% of Total N 21.3% 18.2%
N 349.0 125.0
Mean 22.0 19.2
Minimum 1.3 2.5
Maximum 570.0 142.5
Std. Deviation 35.4 19.9
% of Total N 21.4% 23.9%
N 278.0 97.0
Mean 26.8 21.1
Minimum 1.3 1.3
Maximum 1015.0 84.0
Std. Deviation 67.7 21.0
% of Total N 17.1% 18.5%
N 303.0 91.0
Mean 18.1 20.1
Minimum 2.5 2.5
Maximum 103.8 142.5
Std. Deviation 17.7 22.1
% of Total N 18.6% 17.4%
N 1628.0 523.0
Mean 21.2 20.0
Minimum 1.3 0.6
Maximum 1015.0 525.0
Std. Deviation 35.6 30.5
% of Total N 100.0% 100.0%
Total
BMI Category
Normal
Overweight
Obesity Class I
Obesity Class II
Obesity Class III
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Table 10. 
Multiple comparisons between Age and BMI. 
Dependent Variable: Age 
Tukey HSD
Lower Bound Upper Bound
Overweight -0.88 1.136 .937 -3.99 2.22
Obesity Class I 1.48 1.136 .687 -1.62 4.59
Obesity Class II 4.936
* 1.206 .000 1.64 8.23
Obesity Class III 10.997
* 1.178 .000 7.78 14.21
Normal 0.88 1.136 .937 -2.22 3.99
Obesity Class I 2.37 1.136 .227 -.73 5.47
Obesity Class II 5.821
* 1.206 .000 2.53 9.12
Obesity Class III 11.882
* 1.178 .000 8.67 15.10
Normal -1.48 1.136 .687 -4.59 1.62
Overweight -2.37 1.136 .227 -5.47 .73
Obesity Class II 3.451
* 1.206 .035 .16 6.75
Obesity Class III 9.512
* 1.178 .000 6.30 12.73
Normal -4.936
* 1.206 .000 -8.23 -1.64
Overweight -5.821
* 1.206 .000 -9.12 -2.53
Obesity Class I -3.451
* 1.206 .035 -6.75 -.16
Obesity Class III 6.062
* 1.245 .000 2.66 9.46
Normal -10.997
* 1.178 .000 -14.21 -7.78
Overweight -11.882
* 1.178 .000 -15.10 -8.67
Obesity Class I -9.512
* 1.178 .000 -12.73 -6.30
Obesity Class II -6.062
* 1.245 .000 -9.46 -2.66
Obesity Class III
*. The mean difference is significant at the 0.05 level.
(I) BMI Category
Mean Difference 
(I-J)
Std. 
Error Sig.
95% Confidence Interval
Normal
Overweight
Obesity Class I
Obesity Class II
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Table 11. 
Crosstabulation between BMI and Gender. 
BMI Category
Male Female
Count 169 196 365
% within BMI Category 46.3% 53.7% 100%
% within Gender 22.0% 20.9% 21.4%
Count 212 153 365
% within BMI Category 58.1% 41.9% 100%
% within Gender 27.6% 16.3% 21.4%
Count 170 195 365
% within BMI Category 46.6% 53.4% 100%
% within Gender 22.1% 20.8% 21.4%
Count 123 168 291
% within BMI Category 42.3% 57.7% 100%
% within Gender 16.0% 17.9% 17.1%
Count 94 224 318
% within BMI Category 29.6% 70.4% 100%
% within Gender 12.2% 23.9% 18.7%
Count 768 936 1704
% within BMI Category 45.1% 54.9% 100%
% within Gender 100% 100% 100%
Gender
Total
Total
Normal
Overweight
Obesity Class I
Obesity Class II
Obesity Class III
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Table 17. 
Multiple comparisons between the log transformed postoperative day one total oral 
morphine equivalent dose and BMI. 
 
Lower 
Bound
Upper 
Bound
Overweight -.11 .05 .30 -.25 .04
Obesity Class I -.01 .06 1.00 -.18 .16
Obesity Class II -.05 .07 .96 -.24 .14
Obesity Class III .09 .06 .57 -.08 .27
Normal .11 .05 .30 -.04 .25
Obesity Class I .10 .05 .36 -.05 .25
Obesity Class II .06 .06 .89 -.11 .23
Obesity Class III .20
* .06 .00 .05 .35
Normal .01 .06 1.00 -.16 .18
Overweight -.10 .05 .36 -.25 .05
Obesity Class II -.04 .07 .97 -.23 .15
Obesity Class III .10 .06 .52 -.07 .27
Normal .05 .07 .96 -.14 .24
Overweight -.06 .06 .89 -.23 .11
Obesity Class I .04 .07 .97 -.15 .23
Obesity Class III .14 .07 .26 -.05 .33
Normal -.09 .06 .57 -.27 .08
Overweight -.20
* .06 .00 -.35 -.05
Obesity Class I -.10 .06 .52 -.27 .07
Obesity Class II -.14 .07 .26 -.33 .05
Obesity Class III
(I) BMI Category
Mean 
Difference (I-J) Std. Error Sig.
95% Confidence Interval
Normal
Overweight
Obesity Class I
Obesity Class II
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Table 21. 
Descriptive statistics for postop day 1 regression variables. 
 
 
Mean Std. Deviation N
Log transformed total morphine equivalent 2.6788 0.8167 1581
Age 56.9798 15.8488 1581
Log transformed BMI 3.4575 0.2610 1581  
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Table 22.
Bivariate correlation - hierarchical regression outliers intact - postop day 1.
ln_total_24_
equiv age ln_bmi
ln_total_24_equiv 1.000
age -.077** 1.000
ln_bmi -.059* -.264*** 1.000
* p<.05. **p<.01.  ***p<.001.
Pearson Correlation
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Table 23. 
Bivariate and partial correlations between log transformed total morphine equivalent 
dose on postop day 1 and predictor variables – hierarchical regression outliers intact. 
 
Bivariate Correlation Partial Correlations
Age -.077** -.095***
ln_bmi -.059* -.078**
* p<.05. **p<.01.  ***p<.001.  
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Table 25.
Bivariate correlations - hierarchical regression outliers removed - postop day 1.
ln_total_24_equiv age ln_bmi
ln_total_24_equiv 1.000
age -.067** 1.000
ln_bmi -.059** -.261*** 1.000
**p<.01.  ***p<.001.
Pearson 
Correlation
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Table 26. 
Bivariate and partial correlations between log transformed total morphine equivalent 
dose on postop day 1 and predictor variables – hierarchical regression outliers 
removed. 
 
Bivariate Correlation Partial Correlations
Age -.067** -.090***
ln_bmi -.059** -.078**
**p<.01.  ***p<.001.  
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Table 28. 
Descriptive statistics for postop day 2 regression variables. 
 
Mean Std. Deviation N
Log transformed total morphine equivalent 2.5287 .93357 511
Age 55.64 16.213 511
Log transformed BMI 3.4499 .26474 511  
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Table 29.
Bivariate correlations - hierarchical regression outliers intact - postop day 2.
ln_total_48_equiv age ln_bmi
ln_total_48_equiv 1.000
Age -.079 1.000
ln_bmi .043 -.214*** 1.000
 ***p<.001.
Pearson 
Correlation
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Table 30. 
Bivariate and partial correlations between log transformed total morphine equivalent 
dose on postop day 2 and predictor variables – hierarchical regression outliers intact. 
 
Bivariate Correlation Partial Correlations
Age -.079 -.077
ln_bmi .043 .023
* p<.05. **p<.01.  
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Table 32.
Bivariate correlations - hierarchical regression outliers removed - postop day 2.
ln_total_48_
equiv age ln_bmi
ln_total_48_equiv 1.000
Age -.076 1.000
ln_bmi .074 -.184*** 1.000
***p<.001.
Pearson 
Correlation
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Table 33. 
Bivariate and partial correlations between log transformed total morphine equivalent 
dose on postop day 2 and predictor variables – hierarchical regression outliers 
removed. 
 
Bivariate Correlation Partial Correlations
Age -.076 -.063
ln_bmi .074 .062
* p<.05.  
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Figure 1. 
Frequency distribution of total postoperative day 1 oral morphine equivalent dose 
prior to transformation. 
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Figure 2. 
Frequency distribution of total postoperative day two oral morphine equivalent dose 
prior to transformation. 
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Figure 3. 
Q-Q of total postoperative day one oral morphine equivalent dose prior to 
transformation. 
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Figure 4. 
Q-Q of total postoperative day two oral morphine equivalent dose prior to 
transformation. 
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Figure 5. 
Logarithmic transformed total postoperative day 1 oral morphine equivalent dose. 
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Figure 6. 
Logarithmic transformed total postoperative day 2 oral morphine equivalent dose. 
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Figure 7. 
Q-Q of log transformed total postoperative day one oral morphine equivalent dose. 
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Figure 8. 
Q-Q of log transformed total postoperative day one oral morphine equivalent dose. 
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Figure 9. 
Mean plot of the log transformed total postop day one morphine equivalent dose X 
BMI. 
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Figure 10. 
Residual histogram for total postop day 1 morphine equivalent dose. 
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Figure 11. 
P-P plot of regression standardized residual for total postop day 1 morphine equivalent 
dose. 
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Figure 12. 
Scatterplot of standardized residuals and standardized predicted values of total postop 
day 1 oral morphine equivalent dose. 
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Figure 13. 
Scatterplot of standardized residuals and standardized predicted values of the natural 
log transformed total postop day 1 oral morphine equivalent dose. 
 
 
 
 
 
 
 
 
 
 139 
 
Figure 14. 
Scatterplot of standardized residuals and standardized predicted values of the natural 
log transformed total postop day 1 oral morphine equivalent dose DV and natural log 
transformed IV, BMI. 
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Figure 15. 
Normal distribution of regression standardized residual for the natural log transformed 
total postop day 1 morphine equivalent dose DV and the natural log transformed IV, 
BMI. 
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Figure 16. 
P-P plot of regression standardized residual for the natural log transformed total 
postop day 1 morphine equivalent dose and natural log transformed BMI. 
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Figure 17. 
Scatterplot of natural log transformed total postop day 1 morphine equivalent dose and 
transformed BMI variables. 
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Figure 18. 
Normal distribution of regression standardized residual – hierarchical regression with 
outliers intact – postop day 1. 
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Figure 19. 
P-P plot of regression standardized residual – hierarchical regression outliers intact – 
postop day 1. 
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Figure 20. 
Scatterplot of standardized residuals and standardized predicted values – hierarchical 
regression outliers intact – postop day 1. 
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Figure 21. 
Partial regression plot of log transformed total postop day 1 morphine equivalent dose 
X age – hierarchical regression outliers intact. 
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Figure 22. 
Partial regression plot of log transformed total postop day 1 morphine equivalent dose 
X log transformed BMI – hierarchical regression outliers intact. 
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Figure 23. 
Normal distribution of regression standardized residual – hierarchical regression with 
outliers removed – postop day 1. 
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Figure 24. 
P-P plot of regression standardized residual – hierarchical regression outliers removed 
– postop day 1. 
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Figure 25. 
Scatterplot of standardized residuals and standardized predicted values – hierarchical 
regression outliers removed – postop day 1. 
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Figure 26. 
Partial regression plot of log transformed total postop day 1 morphine equivalent dose 
X age – hierarchical regression outliers removed. 
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Figure 27. 
Partial regression plot of log transformed total postop day 1 morphine equivalent dose 
X log transformed BMI – hierarchical regression outliers removed. 
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Figure 28. 
Residual histogram for total postop day 2 morphine equivalent dose. 
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Figure 29. 
P-P plot of regression standardized residual for total postop day 2 morphine equivalent 
dose. 
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Figure 30. 
Scatterplot of standardized residuals and standardized predicted values of total postop 
day 2 oral morphine equivalent dose. 
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Figure 31. 
Scatterplot of standardized residuals and standardized predicted values of the natural 
log transformed total postop day 2 oral morphine equivalent dose. 
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Figure 32. 
Scatterplot of standardized residuals and standardized predicted values of the natural 
log transformed total postop day 2 oral morphine equivalent dose DV and natural log 
transformed IV, BMI. 
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Figure 33. 
Normal distribution of regression standardized residual for the natural log transformed 
total postop day 2 morphine equivalent dose DV and the natural log transformed IV, 
BMI. 
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Figure 34. 
P-P plot of regression standardized residual for the natural log transformed total 
postop day 2 morphine equivalent dose and natural log transformed BMI. 
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Figure 35. 
Scatterplot of natural log transformed total postop day 2 morphine equivalent dose and 
transformed BMI variables. 
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Figure 36. 
Normal distribution of regression standardized residual – hierarchical regression with 
outliers intact – postop day 2. 
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Figure 37. 
P-P plot of regression standardized residual – hierarchical regression outliers intact – 
postop day 2. 
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Figure 38. 
Scatterplot of standardized residuals and standardized predicted values – hierarchical 
regression outliers intact – postop day 2. 
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Figure 39. 
Partial regression plot of log transformed total postop day 2 morphine equivalent dose 
X age – hierarchical regression outliers intact. 
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Figure 40. 
Partial regression plot of log transformed total postop day 2 morphine equivalent dose 
X log transformed BMI– hierarchical regression outliers intact. 
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Figure 41. 
Normal distribution of regression standardized residual – hierarchical regression with 
outliers removed – postop day 2. 
 
 
 
 
 
 
 
 167 
 
Figure 42. 
P-P plot of regression standardized residual – hierarchical regression outliers removed 
– postop day 2. 
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Figure 43. 
Scatterplot of standardized residuals and standardized predicted values – hierarchical 
regression outliers removed – postop day 2. 
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Figure 44. 
Partial regression plot of log transformed total postop day 2 morphine equivalent dose 
X age – hierarchical regression outliers intact. 
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Figure 45. 
Partial regression plot of log transformed total postop day 2 morphine equivalent dose 
X log transformed BMI– hierarchical regression outliers removed. 
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